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Introduction 1 
1 Introduction 
The average heart rate (HR) of an adult human at rest varies between 56 – 100 beats per 
minute (bpm), however, HR can be increased by up to 300%. Physical activity or physiological 
stress, for example anxiety, aggression or excitement are characteristically accompanied by 
an HR acceleration to adapt cardiac output to the given circumstances. Adjustment of the HR, 
also known as the chronotropic effect, is a mechanism controlled by the autonomic nervous 
system (ANS). The ANS comprises sympathetic and parasympathetic nerves that regulate the 
firing frequency of the dominant pacemaker of the heart, the sinoatrial node (SAN). The 
sympathetic branch of the ANS induces an increase in HR, whereby the parasympathetic 
branch leads to a decline in firing rate of the pacemaker. A critical determinant of HR regulation 
by the ANS is the second messenger cyclic adenosine monophosphate (cAMP) that promotes 
intracellular signal transduction. A potential target within the SAN are hyperpolarization-
activated cyclic nucleotide-gated (HCN) channels, mainly HCN4 channels, which underlie a 
cAMP-dependent regulation (CDR) 1,2. 
1.1 Architecture of the sinoatrial node 
The primary pacemaker of the heart, the SAN, is the component of the cardiac conduction 
system that initiates the heartbeat. Specialized pacemaker cells within the SAN generate 
spontaneous electrical signals which are conducted to the surrounding tissue.  
 
Fig. 1 Anatomical localization of the SAN. (A) Dorsal view of a gelatin-inflated mouse heart. (B) Epicardial, 
dorsolateral view of the right heart and magnification of the right atrium (RA) and sinoatrial node (SAN) area. The 
SAN is located between the superior vena cava (SVC), the inferior vena cava (IVC) and the sulcus terminalis (ST). 
Further abbreviations: PV, pulmonary vein; PA, pulmonary artery; AO, aorta; LSVC, left superior vena cava, LV, left 
ventricle; RV, right ventricle. Scale bars, 0.5 mm. Images are adapted from 3,4. 
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The SAN was anatomically identified in mammalian heart for the first time in 1907 by Arthur 
Keith and Martin Flack 5. The murine SAN forms an approximately 1.5 mm long, comma-
shaped, three-dimensional structure that is located in the intercaval region of the superior 
(SVC) and inferior vena cava (IVC) (Fig. 1). From the endocardial view, the territory of the SAN 
extends parallel to the crista terminalis (CT) and is laterally delimited by the CT and the 
interatrial septum (IAS). Epicardially the SAN extends along the sulcus terminalis (ST) 6.  
The SAN is functionally almost completely insulated from the surrounding atrial myocytes. The 
insulation is composed of the SAN artery and connective tissue, which create a block zone 
around the SAN to shield it from hyperpolarizing influences from the atrial muscle 7. Connective 
tissue consists of layers of fibroblasts, adipocytes and collagen fibers which are rarely 
interrupted by strands of pacemaker cells that protrude into the right atrial muscle and thereby 
build discrete interdigitations between SAN and atrium 6. However, an additional functional 
barrier is provided by reduced electrical coupling properties of SAN cells which protect the 
tissue from external electrical activation and lead to very low conduction velocity within the 
SAN compared to the atrial muscle. Intercellular connections between the single cells in the 
tissue network are built by gap junctions that are composed of connexin (Cx) proteins 8. 
Pacemaker cells exhibit a lower number of gap junctions and a characteristic pattern of Cx 
protein expression compared to atrial cells. Interestingly, Cx43, an ubiquitous member of the 
Cx family in the working myocardium, is absent in the SAN although Cx45 6 and Cx40 9 are 
expressed. Conduction velocity in the SAN is additionally reduced due to a lower depolarization 
rate in pacemaker cells compared to the working myocardium. The diastolic membrane 
potential of pacemaker cells is mainly driven by relatively slow L-type calcium currents instead 
of fast sodium currents found in other cardiac tissue 10. 
The SAN can be subdivided into three major pacemaker compartments: head, body, and tail. 
Cell morphology and fibre orientation vary in these different regions of the SAN. The head of 
the SAN is located near the SVC and is also called the compact region of the SAN, because 
nodal cells are tightly packed and sparsely separated by connective tissue. The cells in this 
region are very small and poorly organized. In the body of the SAN, the arrangement of the 
cells becomes more regular as cells are orientated perpendicular to the CT. In the more inferior 
part, the tail region, cells are larger, more loosely packed, and oriented parallel to the CT. In 
general, pacemaker cells are smaller compared to atrial cells and contain a lower amount of 
myofilaments.  
Pacemaker cells can be subdivided into three major classes: elongated, spindle, and spider 
cells. Elongated shaped cells are faintly striated, contain one or more nuclei, and exhibit a 
length of approximately 80 µm. Spindle cells have a similar shape but are shorter 
(approximately 50 µm) than elongated cells and are mono-nucleated. Spider cells are 
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irregularly shaped with a various number of branches with blunt ends. The head of the SAN is 
predominantly formed by spindle and spider cells 6,11,12.  
Within the heterogeneous structure of the SAN described above, a small cluster of dominant 
pacemaker cells form the first excitation site within the SAN. During normal sinus rhythm the 
leading pacemaker site is primarily located in the head of the SAN close to the CT. However, 
multiple pacemaker sites are present in the SAN and a pacemaker hierarchy within the SAN 
can be observed with the fastest pacemaker located at the superior part (head) and the slowest 
at the inferior part (tail). The cluster of cells with the fastest firing frequency takes over the 
initiation of the heartbeat and thereby sets the HR. It has been shown, that an acceleration of 
the firing rate by isoproterenol shifts the leading pacemaker position superiorly within the SAN, 
whereby a decrease in firing rate by acetylcholine (ACh) shifts the leading pacemaker site 
more inferiorly within the SAN 13. This phenomenon of multiple pacemaker sites and a shift of 
the leading pacemaker is thought to be due to regional differences in ionic current density 
within the SAN 14.  
From the leading pacemaker site, the signal propagates slowly to the right atrium (RA) where 
it continuous through different sinoatrial conduction pathways (SACP) to excite the atrium. In 
the murine heart, in general, two SACPs constitute the breakthrough pathways in direction to 
the atrium and result in a sinoatrial conduction time (SACT) of approximately 5 ms 15. 
Subsequently, the signal spreads rapidly through the atria to the atrioventricular node (AVN). 
In addition to the SAN, the cardiac conduction system consists of the AVN, the bundle of His 
and the Purkinje fibres (Fig. 2). Conduction in the AVN is very slow which results in a delay 
between atrial and ventricular excitation and thereby allows for sufficient filling of the ventricles 
with blood before the following contraction. The AVN also serves as a secondary pacemaker 
and takes over the excitation of the heart in the case of SAN failure. Following AVN excitation, 
the signal rapidly propagates through the His-Purkinje system which communicates the 
impulse to the ventricular muscle 12,17. This specific chronologic sequence of electrical events 
is essential for normal cardiac excitation.  
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Fig. 2 Cardiac electrical conduction system. Schematic illustration of the mammalian cardiac conduction system. 
The first excitation site is located in the sinoatrial node (SAN). SAN extends in the intercaval region of the superior 
vena cava (SVC) and the inferior vena cava (IVC) within the right atrium (RA). The atrioventricular node (AVN) is 
located between the central fibrous body (CFB) and the tricuspid valve (TV). The atrioventricular bundle (AVB) splits 
up in two bundle branches (BB) that branch out to the left and right purkinje fibre (PF) network. Further 
abbreviations: LA, left atrium; PV, pulmonary veins; MV, mitral valve; RV, right ventricle; LV, left ventricle. Image is 
adapted from 1,16.  
1.2 Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels 
A specific characteristic of pacemaker cells allows for its ability to generate spontaneous action 
potentials (AP). SAN cells do not exhibit a stable resting membrane potential. Instead, the AP 
reaches its maximum diastolic potential (at approximately -55 to -60 mV) and is automatically 
followed by depolarization of the membrane which results in the ensuing AP 18. Pacemaker 
automaticity depends on a specific ion channel expression profile of SAN cells. Almost all 
cardiac pacemaker cells express hyperpolarization-activated cyclic nucleotide-gated (HCN) 
channels.  
HCN channels are nonselective cation channels mainly permeable for Na+ and K+ and thereby 
constitute a depolarizing inward current termed If, (funny), Iq (queer) or Ih (hyperpolarization; 
for the present thesis the term Ih is used). HCN channels are named after their specific feature 
to be voltage-gated but activated upon hyperpolarization and deactivated by depolarization. 
Consequently, Ih current significantly contributes to a depolarizing current during diastole. This 
current is a key determinant of pacemaker automaticity and is called slow diastolic 
depolarization (SDD). SDD facilitates opening of other voltage-gated channels, like T-type or 
L-type calcium channels and thereby promotes the generation of an AP. The slope of SDD 
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determines the firing frequency. A second feature of HCN channels is their ability to be 
modulated by a second messenger, the cyclic nucleotide cAMP. Binding of cAMP modifies the 
gating properties of HCN4 channels by facilitating opening of the channels 19–22.  
HCN channels are mainly expressed in the heart and central nervous system where they have 
been studied in detail since their discovery. In addition, HCN expression has been reported in 
other tissues like pancreatic B cells, the enteric nervous system and the urinary bladder, 
however, their physiological function in these tissues is still a matter of debate 23–26. HCN 
channels comprise a small gene family of four distinct members (HCN1 - 4). In the human and 
murine heart all four HCN channel isoforms have been detected with varying expression levels 
in the different cardiac regions. In SAN, HCN4 is the major isoform carrying 80% of Ih, while 
HCN1 and HCN2 account for the remaining fraction of the current. A profound expression of 
HCN1 and its contribution to Ih was recently identified in mouse SAN tissue. In other parts of 
the conduction system, like AVN and Purkinje fibres, HCN4 also forms the major isoform 27,28. 
However, HCN3 is not expressed in the conduction system and was found to play a pivotal 
role in the repolarization process of the ventricles 29.  
1.2.1 Properties of the HCN channel core unit 
HCN channels are part of the pore-loop cation channel superfamily and form a subfamily 
together with cyclic nucleotide-gated (CNG) channels and K+ channels of the ether-à-go-go-
type (KCNH) that is characterized by a cyclic nucleotide-binding domain (CNBD) 20,30. 
HCN channels consist of four subunits that are organized in the cytoplasmic membrane to 
build a central pore in form of homo- or heterotetramers 31. Each subunit consists of three 
major domains: the channel core region, the cytosolic N-terminus and the cytosolic C-terminus 
(Fig. 3). The most critical region for channel function is the core region which is formed by six 
alpha-helical transmembrane segments (S1 - S6). Segments S5 and S6 build the channel´s 
pore which is connected by an S4 - S5 linker to the voltage sensing domain (VSD) formed by 
S1 - S4. 
Introduction 6 
 
Fig. 3 Schematic structure of an HCN channel.  Illustration of a single subunit and the corresponding HCN channel 
tetramer (inset). One subunit comprises six transmembrane segments (S1 - S6) and the cytosolic N- and 
C-terminus. The pore of the channel is formed by S5 and S6. An incorporated GYG motif serves as selectivity filter. 
The pore is connected by a S4-S5 linker to the voltage-sensing domain (VSD) represented by S1 - S4. The 
C-terminus comprises the C-linker (A´ - F´) and the cyclic nucleotide binding domain CNBD (A, B, C, and P) where 
cAMP is able to bind. Letters A - F stand for α-helices. Figure is adapted from 32. 
In addition, the pore contains a characteristic amino acid sequence: glycine-tyrosine-glycine 
(GYG). This specific motif serves as the selectivity filter, conforms to the motif found in K+ 
channels, and is essential for K+ selectivity 33. Since HCN channels are found to be 
nonselective cation channels permitting K+ over Na+ by a ratio of approximately 4:1 20, the 
molecular basis of ion selectivity was recently investigated by cryogenic electron microscopy 
of the human HCN1 channel 34. In K+ channels ion selectivity is served by four binding sites 
provided by carbonyl oxygen atoms that coordinate K+ within the GYG motif 35. However, in 
HCN channels a conformational difference in tyrosine of GYG sequence results in only two 
cation binding sites and therefore explains the nonselectivity of HCN channels 34. 
The gate of HCN channel´s pore is formed by the intracellular end of transmembrane segment 
S6 which possesses properties of a “hinge” that moves during channel gating. This particular 
process of gating is controlled by two gating domains in HCN channels: the transmembrane 
VSD and the intracellular CNBD. VSD is located in the S4 helix which is composed of multiple 
positive charged amino acid residues (arginine and lysine) at every third position 36. These 
charges along S4 detect changes in membrane potential resulting in a transmembrane 
movement of S4 which triggers the opening of the pore gate 37. Despite the fact that all voltage-
gated members of the pore-loop cation channel superfamily share a similar topology of VSD, 
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in HCN channels the gate opens only upon hyperpolarization and closes during depolarization 
of the plasma membrane. The molecular specificity of gate opening during hyperpolarization 
is still a matter of debate 38.  
It has been recently discovered that S4 of HCN channels exhibits an extraordinary length with 
two additional helical turns compared to other voltage-gated channels. Thereby, S4 extends 
further into the cytoplasm where it brings the S4 - S5 linker into contact with the C-linker of a 
neighboring subunit. It was hypothesized that in the depolarized conformation, force exerted 
by S4 leads to a twist of the C-linker and thereby stabilizes closure of the pore. It was proposed 
that during hyperpolarization of the cell a displacement of S4 releases the constraints on the 
C-linker and S6 which allows the pore to open 34. However, after truncation of S4 in HCN1 by 
three helical turns, activation upon hyperpolarization was still preserved which implies that the 
length of S4 may not be a critical determinant for the opening of HCN channels during 
hyperpolarization 39. In addition, mutation of the linkage between VSD and the S4 - S5 linker 
revealed that the S4 - S5 linker is not required for hyperpolarization-dependent activation 40.  
1.2.2 Properties of the HCN channel cAMP binding module  
HCN channels harbor a CNBD in the intracellular C-terminal region where cyclic nucleotides 
are able to bind to the channel. The binding of cAMP to CNBD accelerates the activation 
kinetics and shifts the voltage dependence of activation to more positive voltages. This 
modulation causes the channels to open faster and more completely in the presence of 
cAMP 21,41. However, cAMP is not the only cyclic nucleotide that can bind to HCN channels. 
Both, cyclic guanosine monophosphate (cGMP) and cyclic cytosine monophosphate (cCMP) 
are ligands of the binding domain but exhibit a 30-fold lower affinity compared to cAMP 20,42.  
The molecular determinants and the structural changes of the C-terminus upon binding of 
cAMP in the murine HCN2 channel 41, the human HCN4 channel 43, and the human HCN1 
channel 34 were elucidated recently by cryo-electron microscopy and crystallographic 
techniques. Each of the four subunits of the HCN channel contains an intracellular CNBD 
domain which is connected by a C-linker to the transmembrane segment S6 of the pore. The 
C-linker consists of six α-helices, indicated as A´ - F´. Each helix is separated by short loops. 
Helices E´ and F´ are in contact with the subsequent CNBD, a mixed structure of four α-helices 
(A, P, B, C) and an eight-stranded β-roll. The β-roll is arranged in a β-jelly-roll configuration 
and forms the cyclic nucleotide binding pocket. The pocket contains several highly conserved 
residues that form electrostatic and hydrogen-bonding interactions to provide binding affinity. 
Binding of cAMP induces a conformational change by stabilizing the P-helix and by rotation of 
the B and C helices towards the β-roll. This rotation exerts an upward force on the C-linker. 
Consequently, the C-linker rotates in a counterclock manner to the S6 helical bundle of the 
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channel´s gate and thereby unwinds S6. This “twist-open” mechanism leads to a dilation of the 
gate, facilitating channel opening. However, this mechanism alone is insufficient to open the 
channel in the absence of hyperpolarization 30,34,41,43. 
Within the HCN channel family the individual Ih currents differ from each other with respect to 
their activation time constants, their steady-state voltage dependence and their extent of 
cAMP-dependent modulation. Briefly, HCN3 shows slow activation kinetics and was found to 
be insensitive to cAMP, similar to HCN1 which reveals only a weak shift of the activation curve 
in presence of cAMP. However, HCN1 shows the fastest opening kinetics within the HCN 
channel family. HCN4 and HCN2 are highly modulated by cAMP, and binding of cAMP 
produces a 10 – 25 mV depolarizing shift in the half-maximal activation potential V0.5, which 
indicates that channels are activated at more depolarized voltages when cAMP levels are 
elevated 20,32.  
1.3 The role of cAMP-dependent regulation of HCN4 channels 
Since HCN4 is the predominant HCN channel isoform expressed in SAN pacemaker cells and 
human HCN4 channelopathies are associated with a cardiac phenotype characterized by sinus 
bradycardia, it has been considered that CDR of HCN4 is the key mechanism of HR control by 
the ANS. It is believed that an upregulation of intracellular cAMP levels leads to an increase in 
HR given by HCN4 CDR, whereby a decline in cAMP level decreases HCN4 channel opening 
kinetics and slows HR 1,27,44. 
Intracellular cAMP is generated by the enzyme adenylyl cyclase which catalyzes the 
conversion of adenosine triphosphate (ATP) to cAMP. Adenylyl cyclase can be inhibited or 
activated by guanine nucleotide-binding proteins (G proteins) originating from transmembrane 
G protein-coupled receptors (GPCRs) 45. GPCRs involved in the autonomic regulation of the 
SAN are type-2 muscarinic receptors (M2-receptors) that bind the neurotransmitter ACh and 
beta-1 adrenergic receptors that are able to bind noradrenaline. The signal pathways 
described are regulated by the ANS. The cardiac ANS consists of two major components, the 
sympathetic branch and the parasympathetic branch. In general, the sympathetic branch 
accelerates HR, while the parasympathetic branch decreases HR. Briefly, sympathetic 
efferents release noradrenaline which binds to beta-1 adrenergic receptors, thereby activating 
adenylyl cyclase resulting in an increase in cAMP. In contrast, parasympathetic efferents 
release ACh which binds to M2-receptors, thereby inhibiting adenylyl cyclase and decreases 
the cAMP level 46. 
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To precisely determine the functional significance of HCN4 channels and their modulation by 
cAMP, several genetic mouse studies have been recently implemented. Experiments using 
mice with global HCN4 disruption as well as mice with a selective deletion of HCN4 in 
cardiomyocytes revealed that HCN4 is essential for embryonic pacemaker development. Both 
mutations led to death in utero between embryonic days 9.5 - 11.5. The beating frequency of 
hearts from HCN4-deficient embryos was significantly reduced and hearts did not respond to 
β-adrenergic stimulation and to the associated cAMP stimulation 47. In addition, mice carrying 
a mutation in CNBD that abolished cAMP binding also died at the embryonic stage and the 
embryonic hearts similarly did not respond to cAMP. Together, these investigations indicate 
that CDR of HCN4 is indeed essential for HR control 48. However, studies on adult mice with a 
temporally, tamoxifen-induced deletion of HCN4 contradicted these findings. In the study of 
Baruscotti et al 49 mice showed severe bradycardia and died 5 days after tamoxifen treatment. 
In contrast, the inducible HCN4 knockout in the work of Herrman et al 50 was not lethal but also 
showed cardiac arrhythmias characterized by recurrent sinus pauses. However, in both studies 
HR response to sympathetic drugs was preserved. This argues against a major role of HCN4 
in principal HR control but suggests the channel to be essential for impulse generation and to 
maintain stable cardiac rhythm.  
Analyses of human HCN4 channelopathies also support a key role of HCN4 channels in heart 
rhythmicity. Since 2003 several loss-of-function mutations in the HCN4 gene were identified 
and have been associated with sinus node dysfunction including sinus bradycardia. Notably, 
two of the previously known mutations in human directly affect cAMP modulation of HCN4, 
namely 573X 51 and 695X 52. Studies of these mutations indicated that CDR of HCN4 
determines basal HR but is not critical for autonomic HR control 52,53. However, this data does 
not specifically provide additional insights into the role of HCN4 CDR due to an alteration of 
the general HCN4 architecture itself by truncation of the CNBD. In addition, all patients were 
heterozygous for the HCN4 mutation and therefore express the mutation in only one allele 44,54.  
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1.4 Optical mapping to investigate spontaneous generation and spread of cardiac 
excitation 
In the last decades, investigations of cardiac electrophysiology have mainly focused on the 
cellular mechanisms using microelectrode techniques performed on single cells or on 
multicellular preparations. These experiments elucidated fundamental knowledge about the 
electrical properties of single cardiac cells. However, to fully understand heart physiology it is 
crucial to consider the heart as a functional syncytium of many electrically and mechanically 
connected cardiomyocytes 55. Convenient methods, like electrocardiography, surface 
electrode measurements or ultrasound imaging techniques to investigate electrophysiological 
properties on the whole heart or on the tissue level suffer from low spatial resolution and are 
not able to precisely elucidate network behavior within the tissue 56.  
In the 1970s molecular probes were discovered that bind to the plasma membrane of 
neurons 57 and cardiac cells 58. These dyes follow changes in transmembrane potential by 
changes in fluorescence signal. These findings marked the birth of optical imaging techniques 
in excitable tissue. It is a method to precisely map and retrace electrical processes within 
cardiac and neuronal tissue by the usage of voltage-sensitive dyes and is therefore also 
referred to as optical mapping or voltage-sensitive-dye imaging. Fluorescent dyes used for this 
technique are fast-voltage-sensitive probes that are able to follow voltage changes in a time 
scale of microseconds 59. The dyes are embedded into the cell membrane and respond to 
potential changes by changing their spectral properties. There are several theories which 
explain their voltage sensitivity. One is the solvatochromic theory implying that the electrical 
field induces a molecular rearrangement of the fluorescent probe within the membrane and 
thereby leads to a change in fluorescence 60,61. Another explanation is provided by the 
electrochromic theory. There, it is thought that excitation of the tissue induces an 
intramolecular relocation of electronic charge along the electric field gradient 56,62.  
Until now, series of potentiometric probes, including merocyanines, oxonols and styryl dyes 
have been discovered. However, styryl dyes exhibit specific properties that are required for 
cardiac optical mapping: fast-response, high signal-to-noise ratio, linear change of 
fluorescence with membrane potential changes and less phototoxicity of the dye 55. Styryl dyes 
have been discovered in 1985 and demonstrate a group of dyes with appropriate qualities for 
optical recordings of membrane potentials 63. Important members of this chromophore family 
are for example the dyes RH237, RH421, Di-4-ANEPPS and Di-8-ANEPPS. The molecular 
structure of Di-4-ANEPPS and Di-8-ANEPPS is an aminonaphthylethenylpyridinium (ANEP). 
These dyes respond to a 100 mV change in membrane potential by a 10% change in 
fluorescence. One limitation of styryl dyes is their depth of penetration which is limited to a 
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range of 0.5 - 2 mm 7,55,64. If a measurement of deeper layers in the heart or of blood-perfused 
cardiac tissue is required, new infrared styryl dyes like di-4-ANBDQPQ or di-4-ANBDQBS can 
be applied 65.  
In general, to perform optical mapping recordings an optical setup including an appropriate 
high-speed photodetector, a proper illumination technique as well as a suitable filter system is 
required. In addition, an appropriate dye and a cardiac contraction blocker have to be chosen. 
Available detectors for optical mapping are photodiode arrays, photomultiplier tubes, charge-
coupled device (CCD) cameras and complementary metal oxide semiconductor cameras 
(CMOS). Illumination of the tissue during recording is given by light-emitting diodes (LEDs) or 
by xenon and halogen lamps. A cardiac contraction uncoupler is required to eliminate motion 
artifacts of the beating heart while recording voltage changes. Convenient blockers are 
2,3-butanedione monoxime, cytochalasin D and blebbistatin, a specific myosin II 
inhibitor 55,66,67. Importantly, the components have to be carefully chosen for the data intended 
to obtain by the user. The recorded optical signals allow for the exact localization of the leading 
pacemaker and the excitation pattern within the tissue 13. In addition, the method provides a 
tool to measure conduction velocity and action potential duration 64. 
1.5 Technique to investigate autonomic SAN regulation in vivo 
As described above the cardiac conduction system is innervated by several efferent neurons 
of the ANS. The cardiac parasympathetic nerves are part of the vagus nerve. The sympathetic 
fibers project from autonomic ganglia along the cervical and thoracic spinal cord to the 
superficial layers of cardiomyocytes 68. The region where nerve fibers innervate cardiac tissue 
is called intrinsic cardiac neuronal plexus. The SAN network is supplied by four epicardial 
nerves deriving from both, the dorsal right atrial and right ventral nerve subplexus 1,69.  
Both, parasympathetic and sympathetic branch of the ANS are closely connected to each other 
and are activated simultaneously to keep the HR in a physiological range during rest or to 
adjust the HR during exercise. Changes in sympathetic activity are very slow (located in a 
range of 2 - 10 s) compared to changes in parasympathetic drive which are in the millisecond 
range (200 - 650 ms) 70,71. The normal HR is not constant, but slightly fluctuates around a mean 
value. These fluctuations are called physiological heart rate variability (HRV). It is associated 
with several physiological processes including respiratory cycle, periodical changes in arterial 
blood pressure and peripheral vasomotor activity. An alteration in the physiological HRV can 
give a hint for deficient response to autonomic SAN regulation. Therefore, HRV data can be 
used as indicator for ANS response 3,72–74.  
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An additional parameter is the baroreceptor reflex. Blood pressure (BP) and HR are closely 
intertwined with each other due to the reflex mechanisms. In order to control short-term BP 
changes the ANS becomes activated to adjust HR to the given circumstances. Nerve endings 
of stretch-sensitive neurons sense BP changes in the walls of the aorta and carotid sinus by 
the use of baroreceptor mechanosensors PIEZO1 and PIEZO2 75. Signals are transmitted to 
the central nervous system and are then communicated to the parasympathetic and 
sympathetic branches of the ANS to adapt the HR. In conclusion, characteristics of 
baroreceptor reflex on HR regulation can be used as benchmark for SAN response to ANS 
innervation. 
1.6 Mouse model with disrupted CDR of HCN4 channels (HCN4 FEA mice) 
Since several key questions of the role of HCN4 CDR still remain unanswered, a novel mouse 
model with genetically disrupted cAMP binding to HCN4 channels was investigated for the 
present thesis. This mouse line was generated in the laboratories of Prof. Martin Biel and Prof. 
Christian Wahl-Schott 76. In this mouse line (HCN4 FEA) three amino acid exchanges were 
introduced in the murine hcn4 gene locus (Y527F, R669E, and T670A) (Fig. 4). T670A and 
R669E led to complete insensitivity of HCN4 to cAMP, whereby general HCN4 channel 
architecture was kept intact. These point mutations are located in the loop between the P helix 
and β7 sheet of the β-roll within the CNBD. Since both amino acid residues located at these 
positions directly interact with the phosphate group of cAMP, they were chosen to eliminate 
the high affinity binding of cyclic nucleotides. Advantages over other mutant mouse models in 
this field are that C-terminus and CNBD are completely preserved and mice do not carry genes 
from other species. Notably, in the mouse line HCN4-573X mentioned above, mutation led to 
total truncation of CNBD and parts of the C-linker 53. The third amino acid exchange, Y527F in 
the C-linker, ensured the viability of the mice by partially mimicking steady-state pre-activation 
of HCN4 by baseline cAMP levels. As described above, previous studies revealed that CDR 
of HCN4 is required for embryonic development. Mutations in CNBD led to a shift of the 
activation threshold to more negative values than the physiological maximum diastolic potential 
of SAN cells. This results in a nearly complete depletion of HCN4 activity which is equivalent 
to a total knockout of the HCN4 channel 47,48. HCN4 channels are constantly pre-activated in 
physiological conditions due to a consistent intracellular presence of cAMP in pacemaker 
cells 77. To mimic pre-activation of cAMP the point mutation Y527F was introduced in the 
C-linker of the HCN4 channel. Exchange of tyrosine to phenylalanine facilitates the gating of 
the channel by shifting V0.5 towards more positive potentials within the physiological range of 
SAN cells.  
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For the targeting strategy of the HCN4 FEA mice 76, a procedure that leads to self-induced 
excision of DNA sequences in sperm of male mice was chosen (Fig. 4C). A selection cassette, 
an ACN cassette, was introduced that carries the testis-specific promoter from the 
angiotensin-converting enzyme (tACE) gene. A Cre-recombinase was linked to the selectable 
marker Neo and to the two genes flanked with loxP elements. During spermatogenesis the 
tACE promoter induces expression of the Cre-recombinase gene, the ACN cassette is excised, 
and a single loxP element remains at the chromosomal locus 78. The targeting vector for HCN4 
FEA mice comprises exons 4 to 7 of the murine HCN4 gene. The point mutation Y527F is 
introduced into exon 4, exon 7 contains the mutations T670A and R669E, and intron number 
4 contains the ACN cassette (Fig. 4C).  
 
Fig. 4 Illustration of the incorporated point mutations in HCN4 FEA mice.  (A) C-terminus of the HCN4 channel and 
key structures for the implemented point mutations (highlighted): Y527 (purple), R669 (orange), and T670 (pink). 
Residues R669 and T670 are located in the loop between the P helix and β-sheet of the CNBD and are required 
for (B) binding of cAMP (blue) within the CNBD. (C) Targeting strategy of HCN4 FEA knock-in animals. The gene 
locus comprises exons 3 – 8. Exons 4 and 7 carrying the mutations (Y527, R669 in the CNBD and T670 in the 
C-linker) are depicted in blue. Illustrations derived from human HCN4 channel structure (PDB #Q9Y3QA). Letters 
A – F stand for α-helices. Figure is adapted from 4. 
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2 Aim of the study 
HCN4 is the predominant HCN channel isoform in the sinoatrial node (SAN) and mediates 
80% of Ih. It has been proposed that Ih is crucial for the autonomic control of the heart rate. 
Mechanistically, HCN4 channels and thus Ih activity are regulated via the cAMP system. 
However, the functional role of cAMP-dependent regulation (CDR) of HCN4 channels and its 
relevance for autonomic nervous system (ANS)-mediated heart rate regulation remains to be 
clarified. In the following study these parts are tested by examining a novel knock-in mouse 
line (HCN4 FEA mice) harboring three mutations in the HCN4 channel thereby impairing cAMP 
binding. The present study was launched to experimentally perform cardiophysiological 
analyses on the whole-animal, the isolated organ and the SAN network level. For this purpose, 
the following methods are established beforehand and applied thereafter to the HCN4 FEA 
mouse line. 
(1) In a first step, an optical mapping technique using fast-voltage sensitive dyes should be 
established for three different kinds of heart explants, i.e. isolated whole hearts, intact biatrial 
SAN preparations, and SAN preparations containing the right vagus nerve. This novel tool 
allows for visualization of the first excitation site and the propagation of the electrical signal 
within the specimen under basal conditions, during application of a parasympathomimetic drug 
and during direct vagus nerve stimulation. In a further step, calcium signals of individual cells 
in the intact network of the SAN should be investigated using confocal microscopy.  
(2) Another goal of the present thesis is to establish telemetric recordings of combined 
electrocardiogram (ECG) and blood pressure (BP) and to apply it in vivo. In order to investigate 
the response of SAN firing to ANS activity, the effect of spontaneous vagus nerve inputs should 
be examined by an appropriate analysis of the baroreceptor reflex. Finally, ECG and BP data 
are used for comprehensive characterization of the cardiac phenotype of HCN4 FEA mice. 
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3 Materials and methods 
3.1 Chemicals, solutions and buffers 
Unless otherwise specified, all chemicals used were purchased from Merck KGaA, Carl Roth 
GmbH + Co. KG, Thermo Fischer Scientific and Bio-Rad Laboratories. The quality standard 
was either pro analysi or for molecular biological purposes. Highly purified and deionized water 
(Milli-Q water purification system, Merck Millipore®) was used for all working solutions. 
Additionally, solutions for long-term use were autoclaved.  
3.2 Experimental animals 
For the present work, a knock-in mouse line HCN4 FEA (Hcn4tm3(Y527F;R669E;T670A)Biel) provisioned 
by the work of Andreas Scharr 76 and Christian Gruner 79 was used. It carries three point 
mutations in the HCN4 channel. The R669E and T670A mutations are inserted in the loop 
between the P helix and the β7 sheet of the CNBD and lead to a loss of sensitivity to cAMP. 
The third amino acid exchange, Y527F in the C-linker, ensured the viability of the mice by 
partially mimicking steady-state pre-activation of HCN4 by baseline cAMP levels. Mice were 
kept in accordance with legal guidelines in conventional Eurostandard Type III cages under 
SPF conditions, housed in a 12 h dark-light-cycle environment with ad libitum access to food 
(Ssniff; regular feed: R/M-H; breeding feed: M-Z Extrudat) and water. All animal experiments 
were performed according to governmental regulations and approved by the Regierung von 
Oberbayern. Animals used were mice from homozygous and heterozygous breeds. HCN4 FEA 
mice were bred on a mixed background from 129SvJ/C57-Bl6/N mice and did not differ in body 
weight and lifespan from their wild type (WT) littermates.  
3.3 Genotyping of the experimental animals 
3.3.1 Genomic DNA isolation  
Genomic DNA was extracted from mouse ear biopsies by incubation of tissue in 600 µl, 50 mM 
NaOH for 10 min at 95°C. Subsequently, 50 µl of 1 M TrisHCl (pH = 8) were added and samples 
were centrifuged for 6 min at 13000 rpm. DNA present in the supernatant was utilized for 
polymerase chain reaction (PCR).  
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3.3.2 Polymerase chain reaction (PCR) 
PCR was performed to amplify DNA fragments for genotyping of the experimental mice. GoTaq 
polymerase (Promega) and two specific, custom designed primers were used for the PCR 
reaction: HCN4_FEA_for 5’-CTC AAG GTC TCA GCT GAG G-3’ and HCN4_FEA_rev 5’-GTA 
ATG TAA GCA CAC GGT ACC-3’ (Eurofins Genomics).  
 
PCR reaction mixture Volume in µl 
DNA 2 
Primer 1 (10 µM) 2 
Primer 2 (10 µM) 2 
dNTP´s 0.5 
5x Buffer 5 
Taq Polymerase (GoTaq) 0.125 
H2O 11.375 
 
PCR protocol  
Initial denaturation 95°C 2 min  
Denaturation 95°C 30 s  
Annealing 59°C 30 s 40 cycles 
Elongation 72°C 40 s  
Final elongation 72°C 5 min  
 
3.3.3 Agarose gel electrophoresis 
Agarose gel electrophoresis was used to separate DNA fragments of different sizes within a 
matrix of agarose gel. The gel was made using Agarose (peqGOLD, VWR International GmbH) 
at a concentration of 2% in TBE buffer (Tris/Borate/EDTA buffer). In addition, PeqGreen (VWR 
International GmbH) was added for visualization of nucleic acid under UV light. Once the gel 
had set, it was placed in a horizontal electrophoresis chamber filled with running buffer (TBE 
buffer), and loaded with DNA samples and a 6x loading-dye (Thermo Fisher Scientific). For 
migration and separation of DNA, a voltage of 130 - 180 V was applied. DNA bands were 
visualized using a molecular imager (GelDoc 2000, Bio-Rad), and amplicon sizes were 
determined using a 1 kb GeneRuler Plus ladder (Thermo Fisher Scientific). Transgene band 
(HCN4 FEA): 450 bp and WT: 350 bp. 
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3.4 Optical mapping of action potentials in cardiac tissue 
A protocol to measure optical action potentials (OAP) in cardiac tissue was established in 
cooperation with the group and laboratory of Professor Dr. Igor Efimov, Department of 
Biomedical Engineering, George Washington University, Washington DC, in particular by 
assistance of Jaclyn Brennan. The procedure to optically measure transmembrane voltage 
changes in cardiac tissue is described in detail in chapter 4.1. Briefly, the experimental setup 
consisted of an optical mapping system, instruments for electrical recordings and a perfusion 
system. Electrical recordings were performed in parallel with the optical measurements to 
determine HRV parameters and to trace the beating rate of the cardiac tissue over the entire 
experimental procedure. A perfusion system was employed to supply the cardiac tissue with 
Tyrode solution, a physiological electrolyte solution and to maintain a temperature of 37°C. 
Attention was paid to the aortic pressure measurement during perfusion of the heart in order 
to keep the pressure within a range of 70 ± 10 mmHg to simulate physiological perfusion via 
the cardiovascular system. Detailed setup data are presented in chapter 4.1.1. 
3.4.1 List of materials  
Reagents Source 
(±)-Blebbistatin Cayman Chemical Company 
Calcium chloride dihydrate Merck KGaA 
Carbamoylcholine chloride Merck KGaA 
D(+)-Glucose monohydrate Carl Roth GmbH + Co. KG 
Di-4-ANEPPS Merck KGaA 
Dimethyl sulfoxide Carl Roth GmbH + Co. KG 
Heparin sodium 5000 Ratiopharm GmbH 
Isoflurane CP-Pharma H.-Ges mbH 
Magnesium chloride hexahydrate Carl Roth GmbH + Co. KG 
Mucasol® Schülke & Mayr GmbH 
Potassium chloride Merck KGaA 
Sodium chloride Merck KGaA 
Sodium dihydrogen phosphate 
monohydrate 
Carl Roth GmbH + Co. KG 
Sodium hydrogen carbonate PanReac AppliChem 
Dissecting set Source 
Blunt dissecting scissors  Fine Science Tools (FST, cat. no. 14078-10) 
Blunt forceps  Standard Pattern Forceps (FST, cat. 
no. 11000-13) 
Fine forceps Dumont no. 5 forceps (FST, cat. no.11251-20) 
Fine scissors curved FST, cat. no. 14061-09 
Minutien pin (diameter 0.1 mm) Fiebig Lehrmittel 
Tungsten carbide scissors straight  FST, cat. no. 14568-12 
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Vannas spring scissors Straight; 2.5 mm 
blades 
FST, cat. no. 15000-08 
Vannas spring scissors straight; 8 mm 
blades 
FST, cat. no. 91500-09 
Optical mapping setup Source 
Beam splitting system  DLFLSP2R, SciMedia, Brainvision Inc. 
Camera Lens Adaptor SciMedia, Brainvision Inc. 
Condenser lens M5095+AD, SciMedia, Brainvision Inc. 
Dichroic mirror (50 x 70 mm) SciMedia, Brainvision Inc. 
Emission filter long pass (> 600 nm) SciMedia, Brainvision Inc. 
Excitation filter bandpass 531/40 nm BrightLine®, SciMedia, Brainvision Inc. 
Fiber optic light guide SciMedia, Brainvision Inc. 
Focus drive  SciMedia, Brainvision Inc. 
Halogen lamp 150 W MHAB-150W, Moritex 
MiCAM05 Processor SciMedia, Brainvision Inc. 
MiCAM05 Ultima SciMedia, Brainvision Inc. 
Objective 1.6 x, Plan Apo Leica Microsystems, SciMedia 
Objective nosepiece for 2 objectives SciMedia, Brainvision Inc. 
Shutter controller SSC-2, SciMedia, Brainvision Inc. 
Perfusion system Source 
Aortic cannula  Custom-made 
BP Transducer, MLT1199 ADInstruments 
Bubble trap Radnoti Ltd 
Heating coil, 5.5 ml Radnoti Ltd 
In line Luer Injection Port Ibidi® 
Peristaltic pump MINIPLUS 3 Gilson 
Prep. tissue bath Radnoti Ltd 
Stereomicroscope Stemi 2000 Carl Zeiss 
Syringe filter sterile 10 µm PALL Life Sciences 
Temperature controller, ML312 ADInstruments 
Thermocirculator Lauda A100 Lauda-Brinkmann 
Tubing Tygon®, E3603 Carl Roth GmbH + Co. KG 
Other Source 
Needle electrodes, MLA1213 ADInstruments 
Pacing electrode Ag/AgCl Custom-made 
Stimulator Cable, MLA260/L ADInstruments 
Stimulus Isolator, FE180 ADInstruments 
Silk fibre non absorbable 7/0, 0.5 metric,  Resorba Medical 
Data acquisition and analysis Source 
Animal Bio Amp (ECG amplifier), FE136 ADInstruments 
Bridge AMP (Pressure amplifier), FE221 ADInstruments 
BV_Ana, analysis software Brainvision Inc. 
Labchart 8 ADInstruments 
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MATLAB R2015b MathWorks 
MiCAM05 data acquisition software Brainvision Inc. 
PowerLab 8/35, PL3508/P ADInstruments 
Rhythm MATLAB GUI 2012 Laughner et al., 2012 80 
 
Reagent setup Instruction 
Tyrode solution  Dissolve 128.2 mM NaCl, 4.7 mM KCl, 1.05 mM MgCl2, 
1.3 mM CaCl2, 1.19 mM NaH2PO4, 20 mM NaHCO3 and 
11.1 mM Glucose. Adjust the pH by oxygenation with 
carbogen (95% O2, 5% CO2) to 7.35 ± 0.05.  
 
Blebbistatin stock solution Dissolve ±blebbistatin in dimethyl sulfoxide (DMSO) to a 
concentration of 10 mg/ml. Aliquots of 20 µl are stored 
at -20°C. 
 
Blebbistatin solution Dilute 20 µl of blebbistatin stock solution with 1 ml of 
prewarmed (37°C) Tyrode solution  
 
Di-4-ANEPPS stock solution Dissolve Di-4-ANEPPS in DMSO to a concentration of 
1.25 mg/ml. Aliquots of 30 µl are stored at -20°C. 
 
Di-4-ANEPPS solution Dilute 30 µl of Di-4-ANEPPS stock solution with 1 ml of 
prewarmed (37°C) Tyrode solution 
 
3.4.2 Preparations of cardiac tissue used for optical mapping 
In order to perform optical mapping experiments of cardiac tissue, three types of preparations 
were utilized: (1) intact whole hearts, (2) isolated biatrial SAN preparations and (3) isolated 
biatrial SAN preparations containing the intact right vagus nerve. Female mice at the age of 
12 ± 2 weeks were utilized for all experiments. To avoid blood clotting in the coronary arteries, 
mice were injected intraperitoneally with heparin (100 IU/kg) 10 min prior to the experiment. 
Mice were anesthetized using 5% isoflurane in carbogen (95% O2, 5% CO2) and sacrificed by 
cervical dislocation.  
(1) Intact whole hearts 
For dissection of intact whole hearts (Langendorff hearts), mice were placed in a supine 
position to perform a mid-sternal incision. The rib cage was then opened to remove the heart 
while preserving a substantial part of the aorta and the SVC. To avoid damaging or stretching 
the heart and vessels, the heart was excised by fixation at the thymus and cutting cardiac 
blood vessels and midsternal tissue en bloc. The heart was immediately placed in oxygenated, 
pre-warmed (37°C) Tyrode solution and cannulated rapidly (<5 min post mortem).  
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For cannulation of the heart, the ascending aorta was identified and a custom-made cannula 
was introduced in the vessel, so that the tip of the cannula was just above the aortic valve. The 
cannula had two circular notches at a distance 1 and 2 mm from the tip, permitting the aorta 
to be tied to the cannula with silk suture material. Aortic pressure was detected continuously 
by a pressure transducer (BP transducer, ADInstruments). The heart was perfused 
retrogradely via the coronary arteries by applying a constant aortic pressure of 70 ± 10 mmHg. 
Following cannulation of the heart, the lung and thymus were dissected and removed. It was 
also necessary to dissect free the preparation from fat tissue and to shorten the remaining 
pulmonary vessels to obtain noiseless optical measurements of the SAN. The Langendorff 
heart was continuously perfused (aortic pressure 70 ± 10 mmHg) and superfused (20 ml/min). 
ECG traces were recorded (Labchart8, ADInstruments) by placing three needle electrodes 
close to the isolated heart in an approximate Einthoven I configuration.  
(2) Isolated biatrial SAN preparations 
For biatrial SAN preparations, the heart was isolated and cannulated as described previously 
for Langendorff heart preparations. Subsequently, the heart was removed from the perfusion 
cannula and the ventricles were pinned to the silicone (Sylgard® 184) coated floor of the 
superfusion chamber. It was pinned in a position to give access to the anterior site of the heart, 
first of all to remove the ventricles, and secondly to open the right atrium (RA). This was 
achieved by cutting the tricuspid valve along the axis of the SVC and making a second incision 
along the medial limb of the crista terminalis (CT). The atrium was subsequently opened, 
flattened, and pinned to expose the endocardial side of the RA and the SAN. To open the left 
atrium (LA), a cut through the mitral valve towards the LA appendage was performed. A second 
cut through the anterior atrial free wall was performed to open the LA. The interatrial septum 
(IAS) was partially removed to reduce scattering of the optical signal. The resulting specimen 
provided access to the SAN, located between the SVC, the inferior vena cava (IVC), the RA, 
LA and the atrio-ventricular junction (AVJ) (Fig. 5). Three needle electrodes were placed 
around the SAN explant in order to perform ECG recordings. Optical mapping measurements 
were performed as described in the result section 4.1. In order to identify the maximum shift of 
the leading pacemaker upon parasympathetic activation mediated by carbachol application, 
1 µM carbachol was delivered through the perfusion system for 5 - 7 min until steady state was 
reached. ECG data (Labchart8, ADInstruments) was used to calculate the average beating 
rate for a 1 min recording under basal conditions and during steady-state of the carbachol 
effect.  
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In addition, standard deviation of the NN interval (SDNN) and root mean square of the 
successive differences (RMSSD) were calculated for heart rate variability (HRV) analysis.  
SDNN = √
1
𝑛 − 1
∑(𝑁𝑁𝑖 −𝑁𝑁̅̅̅̅̅
𝑛
𝑖=1
)2 
RMSSD = √
1
𝑛 − 1
(∑(𝑁𝑁𝑖+1 −𝑁𝑁𝑖)2
𝑛−1
𝑖=1
 
SDNN describes the total HR variability, whereby RMSSD reflects short-term variations 
between two successive beats. 
(3) Isolated biatrial SAN preparations containing the intact right vagus nerve 
The isolation of biatrial SAN preparations with preserved right vagus nerve were performed as 
described above, with the following modifications. Prior to heart excision, the right vagus nerve 
was identified close to the right carotid artery in the cervical region of the mouse. For this 
purpose, a small incision on the right side of the neck was made, the mandibular glands were 
separated and the right vagus nerve, extending along the right carotid artery was identified. 
Subsequently the nerve was carefully isolated from adjacent tissue using curved forceps and 
a silk suture was gently tied around the nerve to mark the position of the nerve during the 
following preparation steps. The heart was then carefully removed with the intact vagus nerve 
and mounted onto the perfusion system. Biatrial preparation was performed as described 
above, although fat tissue had to be removed with extra caution to avoid injury of presynaptic 
terminals. Three needle electrodes were positioned around the SAN preparation in order to 
track the beating rate throughout vagus nerve stimulation. The nerve was placed on a custom-
made Ag/AgCl stimulation electrode. The experimental procedure is presented in result 
section 4.1.2. 
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Fig. 5 Biatrial SAN preparation with preserved right vagus nerve. (A) Identification of the right vagus nerve in the 
cervical region of a mouse. A ligature was made to mark the upper end of the nerve. (B) Photograph of an isolated 
biatrial SAN preparation used for optical mapping. The preparation was oriented so that the endocardial side faced 
up to give free access to the sinoatrial node (SAN), the right atrium (RA), the left atrium (LA), the superior vena 
cava (SVC), the inferior vena cava (IVC), the crista terminalis (CT), the interatrial septum (IAS) and the atrio-
ventricular junction (IAS). The right vagus nerve (VN) is preserved within the explant.  
3.5 Functional confocal laser scanning microscopy 
3.5.1 Confocal calcium imaging of whole mount SAN explants 
Intact SAN explants of 12 ± 2 week old female WT and HCN4 FEA mice were prepared as 
described in chapter 3.4.2 for optical mapping, except that the LA was removed. In addition, 
the specimen was completely freed from fat tissue and carefully placed in a custom-made 
Sylgard®-coated superfusion chamber. The explant was pinned with the endocardial side face-
up to grant free access to the SAN. Subsequently, the calcium indicator Fluo-4 AM was 
dissolved in DMSO to a concentration of 2 mM, diluted 1:1 with Pluronic F 127 (13% in H2O) 
(Merck KGaA), and added to Tyrode solution to reach an end concentration of 20 µM 
Fluo-4 AM. The explant was loaded with Fluo-4 AM (Thermo Fisher Scientific) at room 
temperature (RT) for 45 min. Subsequently; the SAN explant was continuously superfused 
with oxygenated and warmed (28°C) Tyrode solution containing 0.2 mg/ml of the excitation-
contraction uncoupler blebbistatin. To record calcium signals, an upright Leica SP8 confocal 
microscope with a 20x water objective (HCX APO L 20x/1.00 water, Leica) was used. For 
excitation, a wavelength of 488 nm was chosen and emission was collected >500 nm by a 
hybrid detector. Calcium signals from head, body and tail of the SAN explant were recorded. 
Frames of 443 µm2 were taken for 10 s with an optically pumped semiconductor laser (OPSL) 
at a frame rate of 28 frames/s by imaging with a scan speed of 8 kHz. The dimension of each 
frame was 1024 x 1024 pixels with a pixels size of 0.433 µm. Each frame was scanned in 
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bidirectional line scan configuration (1024 pixels per line). Every region of the SAN was 
subsequently examined for cells displaying highly localized and spontaneous calcium release. 
These cells were counted and normalized to the total surface area measured. Change in 
fluorescence intensity (ΔF) was assessed after background subtraction, and normalized to 
baseline fluorescence F0. Analysis was performed using the Leica LasX image analysis 
software. Following basal measurements, 15 µM (in Tyrode solution) of TAT-TRIP8bnano 
(sequence: YGRKKRRQRRRGGNHSLEEEFERAKAAVESTEFWDKMQAEWEEMARR 
NWISEN, CASLO ApS) 81 a protein that prevents cAMP binding to HCN channels, was added 
to 4 of the WT preparations. After 30 min incubation, SAN explants were scanned and analyzed 
as described above.  
3.5.2 Confocal voltage sensitive dye imaging of whole mount SAN explants 
In order to record the emission spectrum of SAN cell-bound Di-4-ANEPPS in Tyrode solution, 
intact SAN preparations of 12 week old female WT mice were made as described above for 
confocal calcium imaging. 10 min after blebbistatin application, the voltage-sensitive dye 
Di-4-ANEPPS was applied. Di-4-ANEPPS was dissolved in DMSO to a concentration of 
1.25 mg/ml, and diluted in Tyrode solution to obtain a final concentration of 37.5 µg/ml. 0.5 ml 
of Di-4-ANEPPS was slowly applied to the SAN preparation using a 1 ml syringe, and after 
5 min incubation, the tissue specimen was continuously superfused with Tyrode solution 
(28°C). The Leica SP8 confocal microscope was used as previously described (chapter 3.5.1) 
to record the emission in a range of 500 - 750 nm. The software mode xyλ was chosen to scan 
the SAN explant in steps of 10 nm with a 5 nm overlap using an excitation wavelength of 
488 nm. 
3.6 Immunohistochemistry 
In order to immunostain SAN explants for HCN4 proteins, female WT mice at an age of 
12 weeks were used. SAN preparation was performed as described in chapter 3.4.2, with the 
following alterations. Prior to heart removal, small incisions into the liver were made to 
exsanguinate the mouse, reducing the blood volume in the circulatory system. To completely 
free the heart from blood, it was perfused via the left ventricle (LV) and right ventricle (RV) with 
phosphate buffered saline (PBS) at RT, and subsequently it was excised from the animal. 
Following SAN preparation, the tissue was fixed with 4% paraformaldehyde (PFA) in PBS for 
25 min, washed with PBS for 10 min and incubated in immunohistochemistry (IHC) 
permeabilization solution (79.75% PBS, 19.75% DMSO, 0.5% Triton X-100) for 1.5 h on a 
rotary shaker.  
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After washing three times with 10 ml PBS, non-specific antibody binding sites were blocked by 
incubation for 1 h in 5% normal donkey serum in PBS. This was followed by another three 
washing steps and subsequent overnight incubation at 4°C with guinea pig anti-HCN4 antibody 
(αHCN4gp, Alomone labs) (1:200 in PBS). The SAN explants were washed three times with 
PBS before incubation with FITC-conjugated donkey anti-guinea pig secondary antibody 
(Merck KGaA) (1:100 in PBS) at RT under exclusion of light for 4 h. Tissue was washed with 
PBS, placed on a microscope slide, mounted with mounting medium (Vectashield, Vector 
Laboratories), and scanned using a Leica SP8 confocal microscope with 10 x magnification. 
FITC was excited by a wavelength of 488 nm and emission was collected in a wavelength 
range of 500 - 600 nm, displayed in green. 
3.7 Combined telemetric ECG and blood pressure recordings 
Combined telemetric ECG and BP transmitters (HD-X11, Data Sciences International) were 
implanted in 4 months old male HCN4 FEA (n = 11) and WT (n = 9) littermates. These devices 
permit simultaneous ECG, arterial BP, subcutaneous body temperature and animal activity 
recordings. A detailed description of the implantation is provided in the result section 4.2.1 of 
the present work.  
3.7.1 List of materials  
Reagents Source 
Acepromazine maleate (Calmivet® Solution 
Injectable) 
Vetoquinol AG 
Atropine sulfate Merck KGaA 
Carprofen (Carprieve®) Norbrook 
Ketamine hydrochloride  Medistar 
Propranolol hydrochloride (±) Merck KGaA 
Sodium chloride solution 0.9% sterile 
Miniplasco Connect 5 ml 
B. Braun Melsungen AG 
Xylazine (Xylariem®) Ecuphar GmbH 
Transmitter implantation devices Source 
Blunt dissecting scissors  Fine Science Tools (FST, cat. no. 14078-10) 
Cotton Tipped Applicator sterile Puritan Medical products 
Forceps - Micro-Blunted Tips Dumont (FST, cat. no.11253-25) 
Forceps straight Semken (FST, cat. no. 11008-13) 
Homothermic blanket system with flexible 
probe 
Harvard Apparatus 
Hot bead sterilizer FST, cat. no. 18000-45 
Needle holder, Halsey FST, cat. no. 12501-13 
Needle holder, Olsen-Hegar FST, cat. no. 12002-14 
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Needle single use No. 17, 0.55 x 25 mm B. Braun Melsungen AG 
Needle single use No. 20, 0.40 x 20 mm B. Braun Melsungen AG 
Needle-suture combination, sterile, 
absorbable (6-0 USP, metric 0.7, braided) 
Resorba Medical 
Needle-suture combination, sterile, silk (4-
0 USP, metric 1.5, braided) 
Resorba Medical 
Povidone-Iodine hydrogel 10% Ratiopharm GmbH 
Sensitive plasters, Leukosilk® BSN medical GmbH 
Surgibond® tissue adhesive SMI AG 
Suture, sterile, silk, non-needled (5-0 USP, 
metric 1 braided) 
Resorba Medical 
Syringe 1 ml sterile Injekt-F B. Braun Melsungen AG 
Trimmer, Wella Contura type 3HSG1 Procter & Gamble 
Vessel Cannulation Forceps FST, cat. no.18403-11 
Data acquisition and analysis Source 
DSI Data Exchange Matrix Data Science International 
DSI Dataquest ART 3.1 Data Science International 
DSI PhysioTel HDX-11 for mice Data Science International 
DSI PhysioTel receivers RPC1 Data Science International 
ecgAUTO v3.3.5.10 EMKA Technologies 
 
3.7.2 Procedure for data acquisition and analysis 
Following implantation of the transmitters, mice were allowed to recover for at least 3 weeks 
before the basal 72 hour-recordings of BP and ECG. The mice were placed in separate 
housing cages with ad libitum access to food and water. In each recording session, the same 
number of WT and HCN4 FEA mice was included to equally distribute environmental 
variations. Signals from six mice were recorded simultaneously using the Dataquest A.R.T 
data acquisition software (Data Sciences International). Transmitters were configured within 
the software and turned on by magnetic activation. Each housing cage was placed on 
individual receiver plates. The receiver plates were shielded from electrical interferences using 
custom-made Faraday cages. All parameters were recorded continuously for 72 hours without 
external perturbations in a 12 h dark-light-cycle environment. ECG and BP signals were 
digitized at 1 kHz, whereby activity was sampled at a rate of 0.1 Hz. Intraperitoneal injections 
of propranolol (20mg/kg in 0.9% NaCl) and atropine (1 mg/kg in 0.9% NaCl) were performed 
in a separate recording session of 4 hours. Propranolol was injected after 1 hour prerun 
whereby atropine was injected 20 min later.  
Data analysis was performed using the ecgAUTO v3.3.5.10 software (EMKA Technologies). 
For baroreceptor sensitivity analysis, a 3 hour-recording during low activity of the mice was 
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analyzed. The related sequence method, established for the present thesis is described in 
detail in the result section 4.2.3. ECG and HRV analysis was carried out as previously 
described 3. Mean, minimum and maximum heart rates (HR) were evaluated from continuous 
recordings over 72 hours. Histograms to determine differences in HR dynamics were 
calculated from 72 hour-recordings. HR values were binned using 50 equally distributed 
sections of 16 in a range from 150 to 950 bpm. To investigate data for HR fluctuation 
characteristics frequency domain analysis and time domain analysis were applied. For 
frequency domain analysis, HR fluctuations in three frequency ranges, named very-low-
frequency band (VLF 0.0 - 0.4 Hz), low-frequency band (LF 0.4 - 1.5 Hz) and high-frequency 
band (HF 1.5 - 4.0 Hz) were determined by spectral analysis. For each mouse, three raw ECG 
strips of 103 s during stable sinus rhythm were plotted as RR tachograms and interpolated by 
third degree spline interpolation at 50 ms intervals. This provided equally spaced points for the 
following Fast Fourier Transformation (FFT). After detrending the data, FFT was performed 
using 1024 spectral points. A Hamming windowing function was applied to avoid spectral 
leakage. Power spectral density plots were determined, and for each time segment of 103 s, 
the total power was calculated as the integral sum of total variability over the total frequency 
range (0.0 - 4.0). In addition, VLF, LF and HF power was obtained for each time segment and 
averaged. Time domain parameters were obtained by calculating SDNN and RMSSD from 
three representative RR time series of 10 min during low activity period (see chapter 3.4.2, 
biatrial SAN preparations). Poincaré plots were created by plotting the RR interval (n) of 20.000 
data points against their successive RR interval (n+1). 
3.8 Data analysis and statistics 
All data are displayed as mean ± SEM unless otherwise stated. N represents the number of 
animals or preparations. For all statistical tests, p<0.05 was considered statistically significant 
(***p<0.001, **p<0.01, *p<0.05). Data analysis was performed using OriginPro8 (OriginLab 
Corporation). Differences between groups were analyzed by Student´s unpaired two-sampled 
t-test. 
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4 Results 
In the present thesis the role of cAMP-dependent regulation (CDR) of HCN4 channels on SAN 
activity was characterized using a multilevel cardiophysiological analysis. Within this context, 
two new methods were established, namely optical recordings of action potentials and 
combined ECG and BP telemetry. These methods were utilized to examine the phenotype of 
HCN4 FEA mice.  
4.1 Optical mapping of action potentials in cardiac tissue 
High-resolution optical mapping of transmembrane voltage changes in cardiac tissue and 
particularly in the SAN is a method to precisely define electrical processes in the heart. This 
novel method was established as part of this thesis to characterize the cardiac phenotype, 
especially on the SAN network level of mice lacking CDR of HCN4. Optical mapping was 
applied to investigate impulse formation and propagation in HCN4 FEA mouse hearts as well 
as to define the exact functional anatomy of the SAN after disruption of CDR.  
Briefly, optical mapping is a fluorescence imaging technique where tissue is stained with a fast 
voltage-sensitive probe. It binds to the plasma membrane of cardiac cells and shifts its 
emission spectrum in response to changes in transmembrane voltage. The changes in emitted 
fluorescence light intensity collected in a defined wavelength range are proportional to changes 
in membrane potential82. Emitted light intensity was detected by a high-speed camera and 
translated into action potentials. For interpretation of optical data, the basic element was to 
calculate the activation times for individual regions of the cardiac tissue. Activation times were 
then used to create isochronal activation maps for defining the exact pattern of excitation within 
the heart and the first excitation site within the SAN. Further parameters determined by 
optically obtained activation times were the sinoatrial conduction time (SACT), the action 
potential duration (APD) and the conduction velocity (Fig. 6).  
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Fig. 6 Parameters determined by optical mapping of cardiac tissue. Activation times (tAct) of individual regions of 
the tissue preparation are used to calculate the action potential duration (APD), to build isochronal activation maps, 
and conduction velocity maps. Data derived from activation maps are used to identify the first excitation site, the 
leading pacemaker within the SAN, and to calculate sinoatrial conduction time (SACT). Further description of the 
parameters is found in chapter 4.1.4 – 4.1.8. 
In the following section the instrumentation setup, the experimental conditions and data 
analysis found to be appropriate for optical mapping of cardiac tissue in order to phenotype 
HCN4 FEA cardiac tissue, are explained in detail.  
4.1.1 Experimental setup 
The experimental setup (Fig. 7) consisted of the optical mapping system (described in 
chapter 4.1.3), instruments for electrical recordings, and of a perfusion system to supply the 
cardiac tissue with Tyrode solution, a physiological electrolyte solution. The perfusion system 
was composed of two peristaltic pumps: one pump was used for retrograde perfusion of the 
preparation and the second pump was used for superfusion (20 ml/min) of the preparation as 
well as to return the perfusate back to the holding reservoir passing a 10 µM filter. Tyrode 
solution was warmed up to 37°C by use of a water jacket and a thermocirculator. In addition, 
it was oxygenated with 95% O2 and 5% CO2 to maintain a pH value of 7.35 ± 0.05 throughout 
the entire experiment. For cannulation and retrograde perfusion of the heart the perfusate was 
pumped in a bubble trap, which was equipped with an injection port and was connected to the 
thermocirculator to maintain constant temperature. The air bubble free solution was then 
pumped in direction of an aortic cannula used for retrograde perfusion of the heart. The 
custom-made cannula had two circular notches at a distance of 1 and 2 mm from the tip in 
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order to mount the heart (described in chapter 3.4.2). Aortic pressure was monitored using a 
pressure transducer installed in-line with the perfusion system and the cannulated heart. The 
pressure was kept at 70 ± 10 mmHg by adjusting the flow rate of the peristaltic pump. In order 
to constantly control the beating rate of the heart, sensing electrodes were placed close to the 
preparation. The obtained electrical recordings were further used to directly compare the 
electrical deflections with simultaneously measured optical signals.  
 
Fig. 7 Experimental setup for optical mapping and perfusion of cardiac tissue. (A) The photograph shows the set-up 
of the perfusion and superfusion system as well as the imaging system. Peristaltic pumps and the buffer holding 
reservoir are omitted for better visibility. (B) Cannulated and retrogradely perfused mouse heart in a superfused 
heating chamber. A pressure transducer is installed in-line with the perfusion system and the aortic cannula. 
Electrodes are placed close to the preparation for electrical recordings. 
4.1.2 Experimental procedure 
The following chapter provides a detailed description of the experimental procedure found to 
be appropriate for optical mapping of cardiac tissue.  
First of all, an appropriate dye to measure membrane potentials in cardiac tissue had to be 
found. Two commonly used dyes, Di-4-ANEPPS and RH237 were tested for the present study. 
Di-4-ANEPPS is excited by wavelengths in a range of 370 - 570 nm (Fluorophore 
specifications, Thermo Fisher scientific) and the emission peak of cell-bound Di-4-ANEPPS is 
located at approximately 590 nm (determined by confocal measurements Fig. 8). RH237 is 
excited by wavelengths in a range of 400 – 680 nm and the emission peak appears at 
approximately 700 nm 83. Fig. 8 shows the emission spectrum of cell-bound Di-4-ANEPPS. 
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Di-4-ANEPPS shows a higher signal quality, a faster staining rate, and lower phototoxicity 
compared to RH237. The internalization rate of Di-4-ANEPPS into the cytoplasm is slightly 
higher compared to other voltage-sensitive dyes, like Di-8-ANEPPS and RH795 84. However, 
the time before internalization of Di-4-ANEPPS was found to be sufficient for short-term 
experiments. In addition, Di-4-ANEPPS can be readout in a ratiometric manner and therefore 
could be used in future experiments for simultaneous calcium fluorescence imaging.  
 
Fig. 8 Emission spectrum of cell-bound dye Di-4-ANEPPS. Confocal microscopic measurement of the emission 
wavelength range in a SAN preparation loaded with Di-4-ANEPPS. Excitation wavelength 488 nm. 
In a next step, an excitation-contraction uncoupler to avoid motion artifacts during voltage-
sensitive dye imaging had to be chosen. The uncoupler blebbistatin is recommended for 
cardiac electrophysiological measurements due to the absence of side effects on the electrical 
activity of the heart. Other pharmacological uncouplers like 2,3-butanedione monoxime and 
cytochalasin D show additional effects on intracellular calcium handling, ion channel kinetics, 
and action potential characteristics. Blebbistatin is an inhibitor of the nonmuscle and skeletal 
myosin II isoform and therefore lowers the affinity of myosin II to actin. Two limitations of 
blebbistatin are that it is highly photosensitive and is prone to precipitate in aqueous media 66,85. 
Warming blebbistatin prior to dissolving it in Tyrode solution was found to minimize 
precipitation.  
To perform optical experiments Tyrode solution was freshly prepared, oxygenated, and 
warmed to 37°C. In the meantime, the perfusion system was first cleaned for 20 min using 2% 
mucasol®, an alkaline cleaning agent, and second washed with 1 l of deionized water. 
Subsequently, 500 ml and 300 ml of freshly prepared Tyrode solution were circulated in the 
perfusion system for whole heart measurements and for biatrial SAN measurements, 
respectively. The solution was continuously warmed and oxygenated. Temperature was 
monitored (ADInstruments, Labchart) and the flow rate of the peristaltic pump for superfusion 
of the preparation was set to 20 ml/min.  
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Optical mapping of intact whole hearts 
Intact whole heart optical recordings were made to create isochronal activation maps and to 
characterize observed arrhythmias. The heart was cannulated as described in chapter 3.4.2 
and was mounted to a Langendorff system to be continuously perfused and superfused with 
Tyrode solution as described above. 15 min after cannulation, 1 ml of blebbistatin solution was 
slowly injected into the bubble trap via a drug port over a time of 5 min. From that moment on, 
work space had to be kept in dark to avoid photo deactivation of the substance. After 
equilibration for 5 min, 1 ml of Di-4-ANEPPS solution was applied via the same port. 10 min 
poststaining, optical recordings of the anterior and posterior side of the heart were performed 
using a sampling rate of 2 kHz, a frame number of 8192 and a spatial resolution of 
approximately 100x100 µm/pixel. According to this, one optical recording had a duration of 
4.096 s. Over the course of the optical recordings, the Langendorff heart should be completely 
covered with Tyrode solution and the superfusion should be turned off to avoid motion artifacts. 
For whole heart measurements it was of importance to avoid air bubbles in the perfusion 
system. Air bubbles in the coronary vessels prevent proper heart perfusion and additionally 
lead to insufficient loading of the preparation with fluorescent dye.  
Optical mapping of isolated biatrial SAN preparations  
Biatrial SAN preparations were mapped to create isochronal activation maps, to calculate 
SACT and to identify the location of the leading pacemaker. These parameters (see chapter 
4.1.4 to 4.1.8) provide detailed information about pacemaker cell function within the intact SAN 
network. SAN preparations were performed as described in chapter 3.4.2. The specimen was 
placed in a silicone (Sylgard®) coated heating chamber, fixed with small pins, and was 
continuously superfused as described above. Electrical recordings were performed 
simultaneously and were used to analyze the beating rate and the corresponding beating rate 
variability parameters. Prior to the optical experiment, the SAN preparations were equilibrated 
in Tyrode solution for 15 min. In a next step, 1 ml of blebbistatin solution was slowly spread on 
the SAN explant using a 1 ml syringe. During this procedure and for an incubation time of 5 min 
the superfusion pump was turned off. 10  min after excitation-contraction uncoupling, 0.5 ml of 
Di-4-ANEPPS solution was applied in the same way as blebbistatin. The SAN preparation was 
stained by fluorescence dye for 5 min followed by provisional optical recordings to examine 
the quality of staining. If required, additional Di-4-ANEPPS application was performed. The 
settings for optical mapping of biatrial SAN preparations were similar to those described for 
whole heart measurements. During the optical recordings superfusion should be turned off to 
avoid motion artifacts. For localization of the leading pacemaker, 5 consecutive optical 
recordings with a time delay of 1 s were made three times, in an interval of 5 min. Location of 
the first activation site within the SAN was examined for each OAP of the 15 files.  
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Optical mapping of isolated biatrial SAN preparations containing the intact right vagus nerve 
Optical recordings of biatrial SAN preparations containing the intact right vagus nerve 
(preparation is described in chapter 3.4.2) were performed as described above with the 
following alterations. After basal measurements the vagus nerve was placed on a 
custom-made Ag/AgCl electrode. For this purpose it was essential that the SAN preparation 
possessed a substantial part of the nerve (>8 mm). This was achieved in advance by dissection 
of the nerve from the rib cage up to the cervical region of the mouse (described in detail in 
chapter 3.4.2). The electrode was positioned out of the superfusion solution to ensure 
conduction of the stimulus to the vagus nerve and to prevent electrical interferences of the 
stimulation signals to the electrical ECG recordings. Ag/AgCl electrodes were chosen for right 
vagus nerve stimulation in SAN explants due to its convenient handling and its small size of 
the silver wires (0.2 mm diameter). Another option was the usage of custom-made nerve cuff 
electrodes, however, this required an extra long part of the nerve. Furthermore, concentric 
bipolar electrodes were tested, but appeared to be inappropriate by reason of their size and 
difficulties in placement of the nerve. Vagus nerve stimulation parameters were set to 4 V, 
1 ms pulse width, and 20 Hz for 30 s. These parameters were found to be optimal, since an 
applied voltage of 4 V was low enough to not injure the nerve and a stimulation frequency of 
20 Hz was appropriate to observe an adequate parasympathetic effect on the beating rate of 
the SAN explant. A frequency of 30 Hz appeared to be too high because it led to a complete 
interruption of the heartbeat. A break of at least 1 min between two pacing cycles was essential 
for recovery of the heart preparation. 
In order to combine vagus nerve stimulation with optical mapping, 5 consecutive optical 
recordings (time delay of 1 s) were performed before, during, and after vagus nerve stimulation. 
Data were used to identify the location of the maximum shift of the leading pacemaker. The 
distance to the leading pacemaker site under basal conditions was calculated and normalized 
to the size of the preparation.  
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4.1.3 Optical mapping system 
The optical recording system (Fig. 9) was built on a vibration isolation table in a room that can 
be shielded from light. It consisted of a high-speed camera (MiCAM05 Ultima, SciMedia) 
equipped with a CMOS (Complementary Metal-Oxide Semiconductor) sensor. A temporal 
resolution of 2000 frames/s was selected for measurements of action potentials in the murine 
heart. The spatial resolution of the camera was 100 x 100 pixels with a pixel size of 
100 x 100 µm and could further be increased by an adjustable condenser lens and a 
1.6 x objective. The excitation light was generated by a 150 W halogen lamp, passed through 
a 531/40 nm bandpass excitation filter and was directed in a beam splitter. There, the dichroic 
mirror directed the light beam through a 1.6x objective onto the sample, loaded with 
Di-4-ANEPPS.  
 
Fig. 9 Schematic illustration of the optical recording system. The excitation path (1-5a) consists of a light source 
(1), an excitation filter (531/40 nm bandpass) (2), a dichroic mirror which reflects the excitation light (3), a 1.6x 
objective (4) and the excitation spectrum of the voltage-sensitive dye (5a) in the cell membrane of the preparation 
(5). The emission path (5b-10) consists of the emission spectrum of the fluorophore (5b), the 1.6x objective (6), the 
dichroic mirror which transmits the emission light (7), an emission filter (600 nm long pass) (8), a condenser lens 
(9) and the detector (CMOS camera) (10). Spectrum of unbound Di-4-ANEPPS in methanol (right). Spectrum 
according to Thermo Fisher Scientific fluorophore specifications. 
The excitation wavelength in the green spectral range led to the dye´s emission spectrum at 
longer wavelengths with a maximum at 590 nm. Voltage-sensitive dyes shift their emission 
fluorescence based on the membrane potential. Depolarization of the tissue led to a spectral 
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shift in direction of shorter wavelengths. A voltage change of +100 mV leads to a shift of 
2 - 5 nm in direction of shorter wavelengths 86. The emission signal was passed through the 
dichroic mirror, a long pass emission filter (> 600 nm) and was collected by the detector (CMOS 
camera). Acquired fluorescent signals were then digitalized, amplified, and visualized by a 
custom software (SciMedia, BVAna).  
The detector quantified the amount of emitted fluorescent light per pixel for wavelengths above 
600 nm. The detected light intensity corresponds to the area under the emission spectrum 
curve (Fig. 10), thereby, a shift of the emission spectrum to shorter wavelengths due to a 
positive change in membrane potential led to a decrease in light intensity. Repolarization of 
the membrane potential shifted the spectrum back in direction of longer wavelengths and thus 
led to an increase in recorded light intensity. Therefore, the sampled fluorescence intensity 
correlates directly with changes in transmembrane voltage. The relative signal change is up to 
10% per 100 mV 55. Data were recorded at a sampling frequency of 2 kHz in form of series of 
matrices. Each pixel of the matrices represents the amount of emitted light for a small group 
of cardiomyocytes within the tissue at a specific time point. By plotting fluorescence intensity 
against time, OAPs were generated. 
 
Fig. 10 Functional principle of voltage sensitive dyes and optical action potential acquisition. Emission spectrum of 
the fluorescent dye Di-4-ANEPPS over the course of an action potential (left). Depolarization shifts the spectrum in 
direction of shorter wavelengths. Repolarization shifts the emission back to the long-wave range. A longpass filter 
(LP) of >600 nm is used. The area under the curve of the emission spectrum (in red) represents light intensity that 
is sampled by the detector. The detector collects fluorescence intensity for each of its multiple pixels at a set 
sampling frequency to build series of matrices (middle). Optical action potential (OAP) of one specific pixel 
represents the change in light intensity over time (right). T1 - 3 represent points in time. Figure is adapted from 82. 
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4.1.4 Signal processing of optical action potentials 
A MATLABTM based Graphical User Interface (RHYTHM), programmed and kindly provided by 
the group of Professor Dr. Igor Efimov (Department of Biomedical Engineering, George 
Washington University, Washington DC) was used for data processing and analysis 80. First, 
OAPs were inverted in order to compare them to action potentials obtained by conventional 
microelectrode measurements or with electrical recordings of the explant (Fig. 11).  
 
Fig. 11 Representative optical action potentials and the corresponding ECG recordings (A) Inverted OAPs of a 
recording file of 4.096 s after 3 x 3 pixel binning. Signals were obtained from the RA of a biatrial SAN explant. 
(B) Corresponding ECG recording monitored during optical mapping.  
Second, background fluorescence was automatically subtracted for each pixel. Each single 
image of the specimen comprises pixels providing relevant fluorescence information and pixels 
outside of the preparation that contain noise distorting optical data analysis. In order to isolate 
relevant pixels for further digital processing the image was first segmented by manually 
cropping the image and second, by applying a threshold criteria. For this purpose, the user 
defines a threshold value above which a pixel is considered as relevant. In addition, raw data 
often contained high-frequency noise (>100 Hz) and had to be processed by spatial and 
temporal filtering (Fig. 12). A common method to improve signal-to-noise ratio is binning. Here, 
adjacent pixels were combined into 3 x 3 pixel blocks and the average value was computed. 
Larger bin sizes should be used with caution, because this can remove important features of 
the OAP.  
Signals were then filtered in time domain using a 100th order band pass filter between a user-
defined low and high pass band threshold frequency. The high-band of the filter was selected 
from a drop-down menu in RHYTHM and was set to 100 Hz. In the next step, drift correction 
was applied to the data. This was required since photo deactivation of the dye or movement 
of the specimen possibly led to a slight drift of the baseline. In order to obtain a steady baseline, 
a 1st - 4th order polynomial was fit to the original data and was subsequently subtracted. In the 
following, the OAPs of each pixel were normalized to a uniform magnitude. Normalized 
maximum fluorescence of 100% corresponds to a maximally depolarized membrane potential, 
whereas baseline fluorescence of 0% corresponds to the resting membrane potential.  
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Fig. 12 Digital signal processing using the MATLAB based GUI RHYTHM.Import of the optical data into the software 
provides a background image of the specimen for better spatial orientation. The area to be examined is cut and 
background noise is removed by data masking. All relevant pixels are spatially and temporally filtered to improve 
signal-to-noise ratio. Drift correction and normalization of the data lead to uniform OAPs. Activation times 
(tActivation) are assigned to all of the pixels for a single action potential propagation. tActivation can be used to 
define action potential duration (APD) at a repolarization level of, for example, 80% (APD80). 
For analysis of the filtered data, the activation time of a single action potential propagation has 
to be calculated for each pixel (Fig. 12). The activation time is defined as the time of the 
steepest part of an OAP upstroke and is determined by calculation of the maximum first 
derivative. To assign the activation times in RHYTHM, the user has to select a time window 
that encompasses the OAP upstroke of all the pixels within a region of interest. Activation times 
can be used to create isochronal activation maps and to calculate the action potential duration 
(APD) per pixel. APD is defined as the duration between the activation time and the time at a 
defined level of repolarization. In RHYTHM, the user can select between 50%, 80% or 90% 
repolarization. The time of 80% repolarization (APD80) describes the time where fluorescence 
intensity is only 20% of its maximum. 
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4.1.5 Isochronal activation maps 
Isochronal activation maps are very convenient to visualize impulse propagation across the 
cardiac tissue (Fig. 13). Each isochrone depicts the pixels and their associated part of tissue 
activated at the same time. To create activation maps, a time window that encompasses the 
OAP upstroke of all relevant pixels was determined. Activation times were calculated and 
isochrones were built to be represented as colored activation map. The corresponding color 
time scale (in milliseconds) specified the earliest point of activation (0 ms) in dark blue and the 
latest activation point in red. In order to determine the origin of activation within the SAN and 
the activation pattern towards the atria, biatrial SAN preparations were optically mapped during 
spontaneous pacemaker activity (Fig. 13A-C). The preparation was orientated so that the 
endocardial side was faced up to give a free view on the SAN. The first activation site, the so 
called leading pacemaker position within the territory of the SAN, was formed by a small cluster 
of SAN cells from where the signal was transferred to activate the RA. A block zone was found 
at the left border of the SAN and two atrial breakthrough points were located along the CT to 
activate the RA. After complete excitation of the RA, the signal crossed the IAS to subsequently 
activate the LA.  
To investigate the activation pattern of isolated whole hearts (Fig. 13D, E), two separate 
isochronal activation maps of atrial and ventricular excitation were built for one single 
heartbeat. The two color time scales for atrial and ventricular excitation showed a time lag 
between the end of the atrial activation and the beginning of ventricular activation, which 
corresponds to the atrioventricular transition time (AV delay). The AVN could not be visualized 
using optical mapping because this method only detects signals of superficial cell layers. 
Optical recordings of whole hearts were performed from the anterior and posterior site in which 
ventricular activation was characterized by distinct regions of early activation. The activation 
maps of anterior positioned hearts showed two breakthrough points on the free walls of the RV 
and LV, but with the RV activating earlier than the LV. When the posterior site was optically 
monitored only one breakthrough point was located in the middle of the ventricular surface.  
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Fig. 13 Isochronal activation maps during spontaneous pacemaker activity. (A) Photograph of a typical biatrial SAN 
preparation used for optical mapping and (B) the corresponding color contour map. The color time scale (right) 
indicates the earliest activation point, in dark blue and the latest activation point, in red. Numbers 1 - 4 describe the 
position of OAPs shown in C. (C) OAPs for 4 regions of interest on the SAN preparation during an AP propagation. 
Activation times are marked. (D) Isolated Langendorff-perfused heart in anterior and (E) in posterior position with 
their corresponding activation maps. Two color time scales represent the atrial and ventricular excitation with a time 
delay of 27 ms representing AV conduction; sinoatrial node (SAN), right atrium (RA), left atrium (LA), right ventricle 
(RV), left ventricle (LV), vena cava superior (SVC), vena cava inferior (IVC), crista terminalis (CT). 
4.1.6 Determination of the leading pacemaker position within the SAN 
Optically generated activation maps of biatrial SAN preparations were used to estimate the 
exact position of the leading pacemaker. The isochrone exhibiting the lowest level, thus 
representing the first excitation site within the tissue, was identified in RHYTHM. To uniformly 
plot the location of the leading pacemaker for each preparation the software ImageJ was used. 
A coordinate grid was placed within a background image captured by the CMOS camera (Fig. 
14). The grid was positioned so that the orthogonal axes cross at the IVC. The ordinate was 
positioned parallel to the CT from superior to inferior direction and the abscissa was running 
from RA to LA direction. In addition, the coordinates were normalized for each preparation by 
setting them in relation to the size of the preparation. The XY position of the first excitation site 
was then plotted and identified within the territory of the SAN. The approximate region of the 
central SAN was determined by IHC staining of a SAN preparation using an HCN4 channel 
antibody.  
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Fig. 14 Identification of the leading pacemaker position within the SAN. (A) Background image of a SAN explant 
marked with anatomical landmarks. Orthogonal axes crossing at the IVC were used to plot the leading pacemaker 
position. The ordinate is placed parallel to the CT from superior to inferior direction. The abscissa runs from RA to 
LA. The dotted line indicates the territory of the SAN. (B) Whole mount immunofluorescence labeling using an HCN4 
channel antibody to localize SAN structure (C) Identification of the first activation site by finding the location of the 
pixel with the lowest level. (D) Illustration of the pacemaker location. The black circle indicates the location of the 
leading pacemaker within the territory of the SAN (axes are normalized to the size of the preparation). Sinoatrial 
node (SAN), right atrium (RA), interatrial septum (IAS), atrio-ventricular junction (AVJ), vena cava superior (SVC), 
vena cava inferior (IVC), crista terminalis (CT). 
4.1.7 Sinoatrial conduction time  
Sinoatrial conduction time (SACT) describes the transition time from the moment of the leading 
pacemaker activation to the earliest atrial activation, the atrial breakthrough point. For this 
purpose, the activation times of both regions were determined and the time interval was 
calculated (Fig. 15). However, to correctly identify SACT, especially in the very fast beating 
mouse heart it had to be considered that the OAP of the SAN is composed of two distinct 
components. The optically mapped SAN signal was always a summation of OAPs recorded 
over a sandwich of tissue composed of atrial and SAN cells (signal layer depth 0.5 – 2 mm) 7. 
Therefore, SAN OAP structure did not exactly correspond with single SAN myocyte recordings 
but showed an additional component due to interferences of atrial signals. OAPs recorded in 
the SAN region consisted of a small and slow SAN upstroke followed by a steep upstroke of 
the atrial signal. Thus, to correctly determine the activation time of the SAN, only the SAN 
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component of the two-phase OAP had to be included in the calculation. SACT in WT mice 
during spontaneous pacemaker activity was 4.86 ± 0.37 ms.  
 
Fig. 15 Determination of the sinoatrial conduction time (SACT). (A) Representative activation map of a biatrial SAN 
preparation. (B) OAP of the leading pacemaker (SAN) and the atrial breakthrough within the crista terminalis (CT). 
Activation times are marked (asterisk and dotted line). (C) Magnification of the OAP in B shows the double 
component of the SAN OAP and an SACT of 5 ms. 
4.1.8 Conduction velocity maps 
Conduction velocity maps (Fig. 16) represent the rate of an electrical impulse and the direction 
of impulse propagation within cardiac tissue for a single AP. In order to calculate conduction 
velocity, the activation time for each pixel is determined and a third order polynomial surface 
is fitted to the activation data. Next, local velocity vectors are calculated from the gradient of 
the fitted surface 80. Data are then represented as a vector field. The lengths of the vectors 
describe the local conduction velocity; the directions of the vectors describe the direction of 
activation.  
 
Fig. 16 Conduction velocity map of a biatrial SAN preparation. (A) CV map is a composition of the vector field (red 
arrows) and the isochronal activation map in grayscale. (B) Magnification of the central SAN region (dotted line from 
A) shows a block zone of signal transmission towards the septum (in black). Crista teminalis (CT) and SAN region 
are highlighted. 
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4.2 Combined telemetric ECG and blood pressure recordings 
In order to investigate dynamic interactions between vagus nerve activity and heart function in 
mice with disrupted CDR of HCN4, combined telemetric ECG and BP recordings were 
performed. Implantation of the transmitters as well as baroreceptor sensitivity analysis was 
established for the present study.  
HR and BP are both under control of the autonomic nervous system (ANS) and are closely 
connected to each other because of the baroreceptor reflex. Baroreceptors in the aortic arch 
and the carotid sinus sense fluctuations of the arterial BP, which has to be maintained within 
a relatively narrow physiological range. As a result, if BP changes the ANS subsequently starts 
to adjust the HR to the given conditions by cAMP modulation. To investigate the consequence 
and degree of the outlined interaction between ANS, BP and HR in HCN4 FEA mice, both HR 
and BP were recorded simultaneously. This requires the implantation of a transmitter 
containing 2 ECG leads and a pressure sensor.  
4.2.1 Surgical implantation of telemetric transmitters  
In order to implant combined telemetric ECG and BP transmitters the following surgical 
procedure was applied. Before surgery, all instruments were sterilized by dry heat using a 
glass bead sterilizer. The work bench was disinfected to assure aseptic conditions. Prior to the 
surgery, each transmitter (Fig. 17A, B) was assigned to a receiver plate (RPC1, DSI) of the 
Dataquest A.R.T system and the serial number of the transmitter was recorded. The transmitter 
was then removed from the sterile package and the ECG leads were shortened to a length 
appropriate for the size of the mouse. For a 12 week-old male mouse, weighing ~30 g, the 
positive lead (red) was shortened to a length of ~45 mm and the negative lead (colorless) was 
shortened to a length of ~40 mm. Approximately 6 mm of the silicone tubing was removed from 
the distal part of each lead to expose the wire. Subsequently, the tips of the electrodes were 
covered with excessive tubing leaving a ~2 mm portion of ECG wire uncovered to record 
electrical signals. The tip cover and the silicone tubing proximal to the exposed wire were 
secured by non-absorbable 5-0 silk suture material (Fig. 17A). During the following steps the 
transmitter was hydrated in 0.9% NaCl.  
The experimental animals were anesthetized with an intraperitoneal injection of 100 mg/kg 
ketamine (Medistar), 15 mg/kg xylazine (Ecuphar) and 1 mg/kg acepromazine (Vétoquinol) in 
0.9% NaCl. The mouse was placed in a supine position on a temperature-controlled surgery 
plate, which was set to 37°C. Subsequently, eye ointment was applied and fur was removed 
from the cervical region of the mouse (Fig. 17C). The incision site was disinfected and loss of 
toe-pinch reflex was confirmed. For better view of the surgical area, a dissecting microscope 
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(OPMI 1FR pro, Zeiss) was used. A 15 mm midline incision through the skin of the neck was 
made (Fig. 17D). The mandibular glands were then separated using cotton tip applicators to 
identify the left carotid artery lateral to the left side of the trachea. After this, the artery was 
isolated from adjacent tissue, using curved forceps (Fig. 17E, F). This had to be done with 
caution to not injure the vagus nerve which is running along the vessel. 
 
Fig. 17 Implantation of a combined ECG and BP transmitter - left carotid artery cannulation. (A) Device for surgical 
implantation consists of the device body, two biopotential leads and a pressure catheter. Serial number is labeled 
on the device body. ECG leads are shortened and tips are insulated. (B) Illustration of the pressure catheter. The 
sensing region consists of a non-compressible fluid and a biocompatible gel. For a correct position of the catheter, 
the cranial occlusion suture of the carotid artery has to be secured at the notch of the catheter. (C) Anesthetized 
mouse prepared for device implantation. (D – L) Step-by step image sequence depicting left carotid artery 
cannulation. (D) Cervical skin incision. (E) Exposure of the trachea to identify the carotid artery localized sinistral of 
the trachea. (F) Isolation of the artery from adjacent tissue. (G) Cranial occlusion suture to ligate the vessel. (H) 
Caudal occlusion suture to temporarily prevent blood flow. (I) Middle occlusion suture to secure the catheter while 
cannulating. (J) Syringe needle with bended tip to insert the catheter in the artery. (K) Cannulation of the carotid 
artery (L) The catheter is advanced and positioned in the aortic arch while secured by the middle suture. 
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Then, three non-absorbable 5-0 sutures were passed underneath the isolated portion of the 
carotid artery. One was placed cranial, just proximal to the bifurcation of the carotid artery, and 
was knotted to permanently ligate the vessel (Fig. 17G). The end of the suture was fixed by 
clamping it in a needle holder. The second suture was placed caudally at a distance of ~5 mm 
to the ligature suture (Fig. 17H). It is used for temporary occlusion of blood flow during 
cannulation of the artery. Therefore, a loose knot was made and the end of the suture was 
tightened and fixed in a second needle holder. The third suture was positioned between suture 
one and two and a loose knot was made to keep the catheter in place while cannulating the 
artery (Fig. 17I). Subsequently, one end of the third suture was taped to the surgery table. 
During the whole procedure the surgical area had to be kept moist using warmed (37°C) 0.9% 
sterile NaCl solution. 
In a next step, the catheter was introduced in the carotid artery. The BP catheter consists of a 
5 cm tubing containing a non-compressible fluid and a biocompatible gel at a section of 4 mm 
from the distal part of the catheter (Fig. 17B). This particular section is the sensing region of 
the catheter. It should be devoid of air bubbles and should not be touched at any time of the 
procedure. Before cannulation, the tip of a 25-gauge syringe needle was bent to an angle of 
~100° to use it as catheter introducer. Subsequently, the caudally placed occlusion suture was 
gently pulled using a needle holder to stop blood flow and to slightly lift the artery (Fig. 17J). 
The artery was then penetrated by the bent needle proximal to the ligation suture and the 
catheter was inserted at once. For insertion the catheter was gripped by vessel cannulation 
forceps just before the sensing region (Fig. 17K). When the catheter reached the occlusion 
suture, the middle suture was tightened to secure the catheter (Fig. 17L). The occlusion suture 
was then loosened and the catheter was moved forward to position it in the aortic arch. The 
appropriate length to insert the catheter depends on the size and weight of the mice. For male 
12 week-old mice, weighing ~30 g the catheter was inserted until the integrated notch of the 
catheter reached the ligation suture (Fig. 17B). To secure the catheter in position all three 
sutures were tied around the artery and the suture ends were cut as short as possible.  
Then, the device body was placed in a subcutaneous pocket on the left flank of the mouse. 
For this purpose, blunt surgical scissors were introduced subcutaneously into the incision and 
a pocket was formed (Fig. 18B). A 1 ml syringe filled with prewarmed (37°C) 0.9% NaCl was 
inserted to rinse the pouch followed by insertion of the transmitter core unit (Fig. 18C, D). 
Subsequently, the ECG leads were arranged subcutaneously in an approximate Einthoven II 
configuration. For this purpose, the positive lead (red) was tunneled subcutaneously and the 
terminal end was fixed to the left caudal rib region by absorbable 5-0 sutures (Fig. 18E). The 
terminal end of the negative lead (colorless) was fixed subcutaneously to the right pectoral 
muscle (Fig. 18F). To not irritate the tissue, the leads were placed laying flat against the body. 
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Both leads were tied together and fixed to the left pectoral muscle using absorbable suture 
(Fig. 18G). The skin was then sutured using non-absorbable 5-0 sutures (Fig. 18H) and the 
knots were sealed with tissue adhesive (Surgibond®, SMI AG).  
 
Fig. 18 Implantation of a combined ECG and BP transmitter - subcutaneous placement of the device body and the 
ECG leads. (A) Mouse after left carotid artery cannulation. The catheter is positioned and secured by the occlusion 
sutures of the artery (trimmed). (B) Subcutaneous pocket on the left flank of the animal formed by using blunt 
scissors. (C) Irrigation of the pouch using 1 ml of prewarmed sterile saline. (D) Transmitter placement in the 
subcutaneous pocket. (E) Placement of the positive lead (red tubing) and fixation of the terminal end to the left 
intercostal muscles using absorbable suture material. (F) Placement of the negative lead (clear tubing). The tip of 
the negative lead is fixed to the right pectoral muscle. (G) Placement of a stay suture to secure ECG leads on the 
chest muscle. (H) Skin closure. Red circles indicate the subcutaneous positions of the lead tips. 
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Finally, povidone-iodine hydrogel 10% (Ratiopharm GmbH) was applied to the wound for 
disinfection and 5 mg/kg carprofen (Norbrook) in 0.9% NaCl was injected subcutaneously for 
postoperative pain relief. In addition, 10 µl/g warmed (37°C) 0.9% NaCl was injected 
intraperitoneally to protect the mouse against dehydration. The mice were placed in separate 
housing cages and were allowed to recover for three weeks before basal 72 hours telemetric 
recordings. 
4.2.2 ECG and BP recordings 
Implanted transmitters allowed for continuous recordings in freely moving mice. Fig. 19 shows 
a representative ECG and BP recording. The ECG trace reflects the electrical activity of the 
heart which is characterized by typical deflections. Depolarization of the atria is represented 
by the P wave which is followed by depolarization of the ventricles, displayed as the QRS 
complex. The T wave represents repolarization of the ventricles and appears inverted in murine 
ECG 87. The duration of one heartbeat corresponds to the distance of two R - peaks; the RR 
interval is used to calculate HR in beats per minute (bpm).  
 
Fig. 19 Telemetric ECG and BP recordings.  (A) Representative ECG trace of a WT mouse. Phases of the cardiac 
cycle are indicated. P wave, QRS complex, T wave and RR interval (B) Corresponding arterial BP data. Systolic 
(SBP) and diastolic blood pressure (DBP) are highlighted.  
The arterial BP rises and falls synchronously with the activity of the heart muscle. Immediately 
after excitation of the ventricles the heart contracts. As a result, blood of the left ventricle is 
ejected, which leads to a rise of the aortic BP. The maximum pressure is called systolic blood 
pressure (SBP). The minimum pressure, before the following cardiac contraction, is called 
diastolic blood pressure (DBP). The pulse pressure, also called arterial pressure is the 
difference between SBP and DBP. 
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4.2.3 Sequence method 
For analysis of interactions between vagus nerve activity and HR in vivo, a method to estimate 
baroreflex sensitivity (BRS), was chosen. The applied method provides information about the 
gain of spontaneous BRS and demonstrates if parasympathetic innervation of the SAN leads 
to an appropriate HR response.  
Since spontaneous BP variability (BPV) leads to an activation of the baroreflex and 
consequently baroreflex efferents adjust the HR to the given conditions, the translation of BPV 
into HRV gives an index of BRS 88. Baroreflex efferents drive HR change by modulation of 
parasympathetic and sympathetic firing. Changes in sympathetic drive are characterized by 
very slow fluctuations in a range of 2 to 10 s, whereby changes in vagal drive are in a range of 
200 - 650 ms 70. Therefore, transmission of high-frequency BPV into HRV is related to a change 
in parasympathetic firing. Hence, when establishing the method, it had to be ensured that only 
high frequency changes were taken into account.  
The applied method is called sequence method, since the beat-to-beat series of SBP and RR 
intervals were screened for short sequences of 3 beats during spontaneous increase or 
decrease in SBP. Short sequences were chosen to only capture high frequency changes 
related to vagus nerve inputs on HR regulation. Increase in SBP over 3 heartbeats leading to 
a reflectory increase in parasympathetic firing consequently slows down HR. A decrease in 
HR results in longer RR intervals. This kind of sequence was defined as up sequence (Fig. 
20A). In contrast, a down sequence was detected when a decrease in SBP over 3 beats was 
associated with parallel rise in HR (Fig. 20B). To estimate the relationship between SBP and 
HR, both parameters were plotted against each other and the slope (ms/mmHg) of the linear 
regression line was determined per sequence (Fig. 20A, B bottom). The mean slope of all 
sequences was then calculated and defined as the gain of spontaneous BRS.  
For each mouse a 3 hour section of the recording during low activity period was screened for 
up and down sequences with the following set parameters: only sequences of 3 beats 
exhibiting a delay between SBP and RR of 1 beat were included in the analysis. The threshold 
for SBP and RR changes was 0.5 mmHg and 2 ms. The correlation coefficient of the slope of 
the regression line from RR/SBP plots was set to >0.85 and only sections exhibiting stable 
SAN rhythm were analyzed. 
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Fig. 20 Estimation of BRS using the sequence method.  (A) Representative BP trace of a WT mouse during an up 
sequence of three consecutive beats (top) associated with parallel increase in RR interval (middle). Representative 
plot of SBP and corresponding RR intervals (bottom). The slope of the regression line for the outlined exemplary 
up sequence was 2.60 (in ms/mmHg) as indicated. (B) Representative down sequence with a drop in SBP and a 
subsequent decrease in RR interval results in a slope of 3.17 ms/mmHg.  
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4.3 Cardiophysiological analysis of a mouse model with disrupted CDR of HCN4 
channels 
In the following section the impact of CDR of HCN4 channels on the pacemaker activity was 
investigated. For this purpose, a multilevel analysis to characterize the cardiac phenotype of 
HCN4 FEA, a mouse model with disrupted CDR was applied. The study combined in vivo 
investigations by the use of ECG and BP telemetry recordings and in vitro studies on different 
tissue levels. Hence, electrophysiology and optical recordings of whole heart preparations and 
intact biatrial SAN preparations were performed. In addition, calcium transients of single SAN 
cells within the intact SAN network were examined. 
4.3.1 In vivo role of CDR of HCN4 channels 
In order to investigate the physiological significance of CDR of HCN4 channel on the cardiac 
function in vivo, analyses of telemetric long-term ECG and BP recordings in freely moving 
animals were implemented. Therefore, 72 h recordings of continuous measurements during 
low and high activity phases of WT (n = 9) and HCN4 FEA (n = 11) mice were evaluated for 
basal HR parameters. The mean HR of HCN4 FEA mice was significantly decreased compared 
to WT (HRMean; WT: 522.9 ± 8.3 bpm; HCN4 FEA: 435.9 ± 13.6 bpm; p = 0.00007) (Fig. 21A). 
This bradycardia was not due to a decreased resting behavior of HCN4 FEA mice as HCN4 
FEA and WT mice displayed similar activity data. Fig. 21C depicts circadian rhythm of HR and 
activity measured in both mouse lines over 72 h during 12 h light/dark cycle. Furthermore, 
significant bradycardia was observed when average HR in low activity (LA) phases and high 
activity (HA) phases were analyzed independently. For all three data sets (72h, 12 h LA, and 
12 h HA), the absolute value of maximum HR (HRmax) and the value of minimum HR (HRmin) 
were compared for HCN4 FEA and WT animals. It revealed, that HRmax and HRmin were both 
shifted to lower values in HCN4 FEA mice (Table 1). In contrast, the relative degree of HR 
regulation dynamics which can be determined by HRmax/HRmin and the HR range which is 
defined as HRmax – HRmin were indistinguishable in WT and HCN4 FEA (Table 1). To further 
evaluate differences in HR dynamics, mean HR histograms over a period of 72 h were created. 
WT histograms of HR were symmetrical with a peak in the middle of the histogram whereby 
HCN4 FEA histograms were shifted to lower values with a left-skewed peak in the low-
frequency range (Fig. 21B). In addition, histograms represent that maximum HR values of WT 
were not reached by HCN4 FEA mice while HR range was similar in both phenotypes. Taken 
together, HR analysis demonstrated that disrupted CDR of HCN4 channel caused marked 
bradycardia throughout the entire HR spectrum.  
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Fig. 21 HR analysis of telemetric ECG recordings. (A) Statistics of HR over a 72 h period. HCN4 FEA mice depict 
a significantly decreased mean, minimal (min) and maximal (max) HR. All values are given in mean ± SEM; 
**p<0.01; ***p<0.001; n(WT)=9, n(HCN4 FEA)=11. (B) Representative histograms of a WT (grey) and HCN4 FEA 
mouse (orange) from 72 h. (C) Regular circadian rhythm of HR (top) and activity (bottom) recorded over a period 
of 72 h in WT (black) and HCN4 FEA mice (orange). Animals display a lower activity and HR during 12 h light/low 
activity phase and a higher activity and HR during 12 h dark/high activity phase. A reduction of HR in HCN4 FEA 
mice was consistently observed during the whole recording period. Graphs are given in mean ± SEM. 
In a next step, ECG data was tested for variability of the HR, since the observed bradycardia 
in HCN4 FEA could be due to a consistent reduction of HR or could be related to HR 
fluctuations and the incidence of frequent sinus pauses. To obtain a first impression of the 
data, RR tachograms and poincaré plots were generated of RR interval time series extracted 
from ECG recordings (Fig. 22). Tachograms of HCN4 FEA mice revealed pronounced HR 
fluctuations compared to WT. When data was graphically represented by poincaré plots, where 
each heartbeat is plotted versus its subsequent heartbeat (RRn on the x-axis versus RRn+1 on 
the y-axis), HCN4 FEA mice demonstrated a high beat-to-beat dispersion and a broad comet-
shaped pattern typically observed in SAN dysfunction. By contrast, scatter plots of WT mice 
displayed less dispersion of the data, located in the high frequency range. 
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Fig. 22 Analysis of RR interval time series (A) Representative tachograms of the RR interval extracted from ECG 
recordings of a WT (upper panel, black) and an HCN4 FEA mouse (lower panel, orange) over a period of 30 s 
during low HR (~400 bpm). (B) Representative poincaré plots of 20000 successive heartbeats for a WT (black) and 
an HCN4 FEA mouse (orange). 
Furthermore, analysis of RR interval time series by statistical descriptors, namely, SDNN and 
RMSSD revealed markedly increased HRV in HCN4 FEA mice compared to WT. Both time 
domain parameters were significantly elevated in HCN4 FEA mice, consistent with dramatic 
fluctuations of the RR interval (Fig. 23A, Table2). RMSSD describes the change in HR from 
one heartbeat to its successive heartbeat and thereby mainly reflects parasympathetic input. 
Frequency domain analysis of HRV of HCN4 FEA mice revealed a markedly increased power 
in all frequency bands (VLF, LF, and HF) compared to WT (Fig. 23B, C, Table 2). 
 
Fig. 23 Time domain and frequency domain analysis. (A) Time domain analysis revealed significantly increased 
SDNN and RMSSD parameters for HCN4 FEA mice compared to WT. (B) Representative power spectral density 
plots of a WT (black) and HCN4 FEA mouse (orange), obtained by frequency domain analysis. (C) Statistics of 
frequency domain analysis. (VLF, very low frequency = 0 – 0.4 Hz; LF, low frequency = 0.4 – 1.5 Hz; HF, high 
frequency = 1.5 – 4.0 Hz). All values are given in mean ± SEM; *p<0.05; **p<0.01; ***p<0.001; n(WT)=9, n(HCN4 
FEA)=11. 
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Finally, HRV analysis revealed dramatic HR fluctuations in HCN4 FEA mice accompanied by 
severe bradycardia. Characteristic parameters of ECG data (time of QRS complex, PQ and 
QT intervals) were similar in WT and HCN4 FEA mice (data not shown). Since it was unclear, 
if generation of HR fluctuations was attributable to ANS input, sympathetic and 
parasympathetic regulation were blocked in vivo by treatment with propranolol and subsequent 
injection of atropine. Both reduced HR fluctuations in WT and HCN4 FEA mice (data not 
shown), which indicated that HRV in HCN4 FEA mice were mainly accountable to intrinsically 
autonomic regulation.  
In the next step, raw ECG and BP traces were further analyzed to evaluate the impact of the 
previously determined bradycardia and sinus dysrhythmia on the hemodynamics of HCN4 FEA 
mice. Analysis of 3 h recordings during low activity phase of the mice revealed a significantly 
reduced DBP in HCN4 FEA mice compared to WT (Fig. 24A, Table 3) (DBP; WT: 86.3 ± 2.0 
mmHg; HCN4 FEA: 79.2 ± 1.9 mmHg; p = 0.0196). In contrast, SBP was relatively constant 
and at similar levels in both phenotypes (SBP; WT: 112.6 ± 1.6 mmHg; HCN4 FEA: 111.1 ± 
2.6 mmHg; p = 0.6241). Data inspection revealed that long sinus pauses in HCN4 FEA mice 
led to extended periods of diastole, the ventricular refilling phases of the heart cycle (Fig. 24B). 
During diastole, arterial pressure dramatically dropped until the following contraction of the 
ventricles led to an ejection of blood into the arterial blood system which led to an eventual rise 
of BP. When SBP and DBP were plotted against their corresponding RR interval it became 
apparent that long RR intervals and in particular sinus pauses correlate with low DBP whereby 
SBP was not affected (Fig. 24C).  
 
Fig. 24 Correlation of HR and BP in HCN4 FEA mice (A) Statistical analysis of DBP and SBP of a 3 h recording 
during low activity phase of the mice revealed significantly lower DBP values of HCN4 FEA mice compared to WT 
but similar SBP data. (B) Representative ECG and BP trace of an HCN4 FEA mouse during a sinus pause which 
is accompanied with a dramatic drop in DBP. (C) Representative plots of 20000 consecutive RR intervals against 
their corresponding DBP (top) and SBP (bottom) values for WT (black) and HCN4 FEA (orange). All values are 
given in mean ± SEM; *p<0.05; n (WT)=9, n(HCN4 FEA)=11.  
Results 52 
On closer inspection of telemetric recordings of HCN4 FEA mice, further anomalies of ECG 
and BP were identified. Data traces were composed of alternating episodes of low and high 
HR. Sections of bradycardia characterized by long sinus pauses and dramatic decrease in 
DBP were followed by periods of increased HR and BP fluctuations. Fig. 25 represents typical 
ECG and BP traces of a WT and HCN4 FEA mouse. WT ECG recordings showed stable sinus 
rhythm with steady BP rise (SBP) and fall (DBP). By contrast, ECG recordings of HCN4 FEA 
mice displayed distinct arrhythmias.  
 
Fig. 25 Telemetric ECG and BP traces of WT and HCN4 FEA mice.  (A) Representative raw ECG (upper panel) 
and BP (lower panel) traces of a WT mouse show a stable rhythmicity. (B) Representative traces of an HCN4 FEA 
mouse revealed periods of slow and fast HR accompanied with BP fluctuations.  
Closer examination of a section during spontaneous accelerated HR revealed two specific 
forms of arrhythmia in HCN4 FEA mice: isorhythmic AV dissociation (IAVD) and junctional 
escape rhythm (JER) (Fig. 26). Both types of dysrhythmia are characterized by the presence 
of a subsidiary pacemaker which compensates slow SAN rhythm and takes over the activation 
of the heart. Therefore, it can be described as a kind of escape mechanisms. During JER, an 
ectopic focus activates the ventricles as well as retrogradely activates the atria which lead to 
short-term episodes of junctional tachycardia. IAVD sustains over longer periods and two 
independent foci exist in parallel: the SAN drives the activation of the atria whereby an ectopic 
focus drives the activation of the ventricles 89. Consequently, P wave and QRS complexes are 
dissociated which lead to fluctuations of the PR interval. Notably, QRS complex morphology 
during escape rhythm is undistinguishable to that during sinus rhythm. Over the course of 
escape phenomena, atrial and ventricular contraction are not properly timed leading to 
insufficient filling of the ventricles and consequently to a decrease in systemic arterial BP 89. 
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Combined telemetric ECG and BP recordings of HCN 4 FEA mice revealed that a decrease in 
PR interval led to a decrease in SBP and DBP (Fig. 26). A return of the rhythm to stable SAN 
conduction led to normalization of BP. Importantly, HR range in HCN4 FEA mice was still 
preserved after excluding episodes during JER and IAVD (data not shown). 
Both types of escape phenomena where identified in telemetric ECG data of HCN4 FEA mice 
and were further analyzed by optical mapping of Langendorff hearts. 
 
Fig. 26 Escape phenomena in HCN4 FEA mice.  Representative telemetric ECG trace of an HCN4 FEA mouse 
(top) depicts alternating episodes of sinus rhythm during low HR and of an escape rhythm during accelerated HR. 
Closer inspection (middle) reveals dissociation of the P waves and QRS complexes which indicates the presence 
of two independent pacemakers. Isoryhthmic AV dissociation (IAVD) and junctional escape rhythm (JER) were 
observed in HCN4 FEA mice. Corresponding arterial BP recordings showed a decrease in arterial pressure during 
successive decrease in PR intervals. Return of the rhythm to normal stabilizes BP. 
JER was characterized by episodes of HR acceleration that alternate with short episodes of 
sinus rhythm. Since HR of HCN4 FEA mice were dramatically reduced, heartbeats partially 
originated from a subsidiary pacemaker that activated both, the atria and the ventricles. The 
ectopic rhythm of a second independent pacemaker was faster than SAN firing and thereby 
suppressed SAN rhythm. During JER the P wave lied hidden in the QRS complex or occurred 
slightly after of before QRS complex. The location of the P wave depends on the location of 
the subsidiary pacemaker. Optical mapping of an HCN4 FEA Langendorff heart during JER 
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verified the existence of a second pacemaker located on the endocardial side close to the AV 
junction and it evidenced its retrograde activation of the atria. Fig. 27 displays optical action 
potentials and a simultaneously measured ECG trace during JER. Isochronal activation maps 
of the atria and the ventricles were created. The interval from the time when atrial activation 
was completed to the time of the first breakthrough of the signal in the ventricles describes the 
transition time through the AV node, the branches of AV bundle and the HIS bundle. Optical 
data only derived from superficial layers of tissue, but conclusions about the location of the 
subsidiary pacemaker within the heart could be drawn from the transition time and the pattern 
of activation. In beat number 1 of Fig. 27 SAN activated the atria, though the signal was not 
conducted to the ventricles. It was blocked by refractory tissue due to subsidiary pacemaker 
activation driving the ventricles. This event led to a shorter PR interval. JER occurred in beat 
number 2, atria were activated retrogradely and ventricles were activated anterogradely at 
once which led to the conclusion that the ectopic focus was located somewhere close to the 
AV junction. In beat number 3 – 5 the ventricular signal preceded the atrial signal and PR 
interval became negative.  
 
Fig. 27 JER during optical recordings of HCN4 FEA Langendorff hearts.  (A) OAPs (upper panel) and surface ECG 
recordings (lower panel) from an HCN4 FEA Langendorff heart during JER. In beat #1 atrial signal occurred slightly 
before ventricular signal. In beat #2 the atrial signal is hidden behind the ventricular signal. In beat #3 - 5 the 
ventricular signal precedes the atrial signal. (B) Ladder diagrams for beat #1 – 5 determined from color time scales 
of the optical data (B left, top) and its schematic ladder diagrams (B left, bottom) indicate atrial (color time scale, 
top), AV (middle) and ventricular (bottom) conduction times in ms. For beat #1 ventricles were activated by an 
ectopic focus 10 ms after atrial activation. In beat #2 ventricles and atria were activated simultaneously. In beats #3 
– 5 atria were activated by the SAN after the activation of the ventricles by a subsidiary pacemaker. Representative 
activation map for beat #1 (right, top) demonstrates normal activation pattern. Activation maps for beat #3 – 5 were 
similar. Activation map (right, bottom) of beat #2 revealed an anterograde activation of the ventricles and retrograde 
activation of the atria from the AV junction.  
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IAVD describes a form of escape rhythm where characteristic flirtatious P waves indicate the 
presence of two independent pacemakers. During IAVD in HCN4 FEA mice the P wave moved 
back and forth across the QRS complex. The SAN activated the atria, however, its firing rates 
oscillated and were reduced. The firing rates of a subsidiary pacemaker remained stable and 
were fast enough to excite the ventricles. This phenomenon was determined by optical 
mapping of an HCN4 FEA Langendorff heart during IAVD (Fig. 28). Data were analyzed as 
described above for JER. Beat number 1 and 3 in Fig. 28 demonstrates regular activation of 
the heart by the SAN. Conduction time was approximately 27 ms. Since the conduction time 
in beat number 2 was less than 27 ms, the ventricles were driven by a subsidiary pacemaker 
whereby the atria were activated by the SAN. In the electrical recordings P wave moved closer 
to the QRS complex. In beat number 4, P wave was hidden behind the QRS complex but atria 
were still activated by the SAN as became apparent by the pattern of the activation (Fig. 
28, #4). In beat number 5, P wave occurred after the QRS complex. In this case, activation of 
the ventricles by a subsidiary pacemaker preceded activation of the atria by SAN. For beat 
number 2 and 5 the activation maps were indistinguishable from that of regular rhythm in beat 
number 1.  
 
Fig. 28 IAVD during optical recordings of HCN4 FEA Langendorff heart.  (A) OAPs (top) and surface ECG (bottom) 
recorded from an HCN4 FEA Langendorff-perfused heart during IAVD. (B) Ladder diagrams (left) for beat #1 – 5 
determined from the recordings presented in (A). Beat #1 and 3 depict regular activation arising from the SAN. 
Conduction time was 27 ms. Beat #2, 4, and 5 depict a shortened or negative PR during IAVD indicating that the 
atria were activated by SAN whereby ventricles were activated by a subsidiary pacemaker. The pattern of activation 
maps for beat #1 – 5 (right) were similar whereby atria and ventricles in beat #4 were activated in parallel and 
therefore one single activation map for the entire activation of the heart could be drawn. 
Taken together, optical mapping of HCN4 FEA Langendorff hearts revealed the presence of 
two independent pacemaker sites, one in the SAN and one close to the inferior vena cava or 
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the AV junction. The subsidiary pacemaker takes over ventricular activation or retrogradely 
activates the atria in circumstances when SAN firing decelerates and therefore acts as escape 
impulse generator. The occurrence of IAVD and JER in HCN4 FEA mice confirms chronotropic 
incompetence of the SAN and indicates that the coordinated response of the SAN and the 
subsidiary pacemaker to HR regulation by the ANS is impaired.  
To further analyze the properties of ANS driven HR regulation in HCN4 FEA mice, dynamic 
interaction between parasympathetic activity and the HR was investigated in vivo. Therefore 
the sequence method, described in chapter 4.2.3 was applied to combined ECG and BP 
measurements during periods of stable SAN rhythm without IAVD and JER. Briefly, data was 
screened for short sequences of three beats during rise (up sequence) and fall (down 
sequence) of SBP that lead to reflectory vagus nerve activation or inactivation which results in 
a subsequent effect on the HR. Each sequence was analyzed for the graphical relationship of 
SBP and HR by calculating the slope of the regression line. Interestingly, HCN4 FEA mice 
showed a higher amplitude and steeper slope for up and down sequences compared to WT 
(Slopeup; WT: 4.21 ± 0.25 ms/mmHg; HCN4 FEA: 7.63 ± 1.23 ms/mmHg; p = 0.0238; Slopedown; 
WT: 4.09 ± 0.39 ms/mmHg; HCN4 FEA: 8.93 ± 1.49 ms/mmHg; p = 0.0103). For both 
phenotypes a similar amount of sequences were identified (Fig. 29, Table 3). These results 
indicated a higher gain of the reflex in HCN4 FEA mice which implies that a loss of HCN4 
channel CDR leads to overshooting responses to vagus nerve activity and that SAN firing is 
more prone to perturbating influences like inputs from the ANS. Therefore, CDR of HCN4 
channel appears to be essential to antagonize and dampen parasympathetic effects on the 
heart and is also required for adequate baroreceptor reflex function. 
 
Fig. 29 HR adaptation to dynamic vagal nerve activity in vivo determined by the sequence method. (A) Statistics of 
the mean slope of RR/SBP relationship. HCN4 FEA mice showed a significantly higher mean slope of the regression 
line in up and down sequences compared to WT. (B) Total amount of up and down sequences in WT and HCN4 
FEA mice indicated in sequences/1000 beats. All values are given in mean ± SEM; *p<0.05; n(WT)=9, n(HCN4 
FEA)=11. 
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4.3.2 Role of CDR of HCN4 channels in the SAN network  
Evidence of chronotropic incompetence of the SAN in HCN4 FEA mice was provided by in vivo 
ECG and BP data analysis. Intact biatrial SAN preparations of WT (n=26) and HCN4 FEA 
(n=31) were investigated by electrical recordings and optical measurements to further analyze 
the impact of disrupted CDR of HCN4 on the SAN network level. Electrical recordings of SAN 
explants revealed significantly pronounced fluctuations of the beating rate in HCN4 FEA 
preparations compared to WT determined by tachograms and the calculation of RMSSD and 
SDNN (Fig. 30, Table 4). In addition, a loss of CDR of HCN4 resulted in a significantly reduced 
beating rate, depicted as the length of NN intervals (Fig. 30, Table 4). These data are almost 
consistent with data derived from in vivo ECG recordings (chapter 4.3.1) even though intrinsic 
autonomic regulation is lacking in in vitro preparations which indicates that the SAN network 
of HCN4 FEA mice by itself is unstable and prone to perturbations.  
 
Fig. 30 Analysis of the beating rates and HRV parameters from biatrial SAN preparations. (A) Representative 
tachograms of biatrial SAN preparations from a WT (left) and HCN4 FEA mouse (right) demonstrate increased 
fluctuations of the NN intervals in HCN4 FEA. (B) Statistics of the mean beating rate, indicated as NN interval (right), 
of the mean RMSSD (middle), and mean SDNN (right). Values were obtained from electrical recordings of biatrial 
SAN preparations over a duration of 1 min. SAN explants of HCN4 FEA mice showed increased values in all three 
parameters compared to WT. All values are given in mean ± SEM; **p<0.01; ***p<0.001; n(WT)=26, n(HCN4 
FEA)=31. 
To further evaluate the cause and impact of SAN network instability, optical recordings of intact 
biatrial SAN preparations were performed to obtain informations about the anatomical structure 
of impulse formation and propagation within the intact SAN network (Fig. 31). Isochronal 
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activation maps of WT and HCN4 FEA preparations showed a similar impulse origin and 
comparable conduction pathways throughout the SAN and atria. In contrast, SACT was 
significantly prolonged in HCN4 FEA explants (n=8) compared to WT (n=7) (SACT; WT: 4.86 
± 0.37 ms; HCN4 FEA: 7.44 ± 0.57 ms; p = 0.0029) (Fig. 31B, Table5). Activation maps of WT 
(n=26) and HCN4 FEA (n=31) were further analyzed for the exact position of the leading 
pacemaker site. This investigation revealed that a loss of CDR of HCN4 channel had no impact 
on the pacemaker position within the SAN during baseline conditions. For both phenotypes the 
impulse origin was similar and remained perfectly stable within the territory of the SAN (Fig. 
31C, D).  
 
Fig. 31 Optical mapping of biatrial SAN preparations of WT and HCN4 FEA mice. (A) Representative isochronal 
activation maps of biatrial SAN preparations of WT (upper panel) and HCN4 FEA (lower panel) and their 
corresponding OAPs derived from SAN region during spontaneous rhythm. (B) Statistics of mean SACT determined 
by optical mapping of WT (n=7) and HCN4 FEA (n=8). Values are given in mean ± SEM; **p<0.01 (C) Coordinate 
system with plotted leading pacemaker position for WT (black dots) and HCN4 FEA (orange dots). (D) Density plots 
demonstrate a similar distribution of the leading pacemaker site within the anatomical borders of the SAN (in grey) 
for WT (left) and HCN4 FEA (right). RA: right atrium; CT: crista terminalis; IVC: inferior vena cava; SVC: superior 
vena cava; AVJ: atrioventricular junction; IAS interatrial septum. 
The hypothesis that disrupted CDR of HCN4 leads to a markedly increased sensitivity of the 
SAN to perturbating influences was further tested by application of a parasympathomimetic 
drug. Treatment of intact biatrial SAN preparations of WT (n=13) and HCN4 FEA (n=16) with 
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1 µM of the ACh analog carbachol reduced the cAMP level and therefore mimicked vagus 
nerve activity. Carbachol led to a decrease in beating rate in both genotypes (Table 5). Optical 
recordings during carbachol application revealed a shift of the leading pacemaker site towards 
the IVC and IAS. The magnitude of the shift was larger in HCN4 FEA SAN explants compared 
to WT, but not significantly different (Fig. 32, Table 5). 
 
Fig. 32 Leading pacemaker position before and during application of a parasympathomimetic drug. (A) Location of 
the leading pacemaker site at baseline in biatrial SAN preparations of WT (black dots, n=13) and HCN4 FEA (orange 
dots, n=16). (B) Leading pacemaker position of WT before (black dots) and during application of 1 µM carbachol 
(red dots). Pacemaker position shifted in n=7 WT SAN preparations. (C) Leading pacemaker position of HCN4 FEA 
before (orange dots) and after application of 1 µM carbachol (red dots). Pacemaker position shifted in n=8 HCN4 
FEA SAN preparations but to a larger extent compared to WT. 
Physiologically, parasympathetic nerve terminals of the right vagus nerve release ACh to the 
SAN. To investigate the effect of physiological, pulsatile, and transient release of ACh, the right 
vagus nerve of WT (n=6) and HCN4 FEA (n=7) biatrial SAN preparations was electrically 
stimulated (VNS, vagus nerve stimulation). VNS at 20 Hz stimulation frequency evoked a 
marked reduction in firing rates of WT and HCN4 FEA preparations. The magnitude of vagal 
bradycardia was not significantly different in WT compared to HCN4 FEA (Table 5). However, 
VNS of HCN4 FEA explants induced overshooting episodes of slow firing rates or even sinus 
arrest which alternated with short episodes of recovery and faster firing rates. In comparison 
to HCN4 FEA, VNS of WT preparations caused a very stable and persistent decrease in 
beating rate (Fig. 33A).  
To adress this effect to the anatomical location of the leading pacemaker position, optical 
recordings during VNS were performed. Electrical stimulation of the vagus nerve caused a shift 
of the leading pacemaker towards an inferior position. The leading pacemaker site shifted 
approximately within the anatomical borders of the SAN in WT. In contrast, VNS of HCN4 FEA 
explants caused an extreme shift of the impulse origin towards the IVC and IAS or even in 
direction of the AV junction (Fig. 33B, D). However, these changed positions of the leading 
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pacemaker were not persistent thoughout VNS but temporarily returned back to their previous 
position (Fig. 33C). Furthermore, the magnitude of the shift was significantly larger in HCN4 
FEA compared to WT (Table 5).  
 
Fig. 33 Leading pacemaker position during vagus nerve stimulation. (A) Representative NN tachograms of biatrial 
SAN preparations of WT (upper panel) and HCN4 FEA (lower panel) before, during, and after VNS. Time interval 
of VNS is marked by a dotted line. (B) Isochronal activation maps of HCN4 FEA preparations represent potential 
positions of the leading pacemaker site (dark blue) during VNS. (C) Representative OAP trace before, during (dotted 
line) and after VNS obtained by optical recordings of 4 s interrupted by 3 s break. Red dots are highlighting signals 
that originate from a different leading pacemaker position compared to baseline position. (D) Location of the leading 
pacemaker site at baseline in biatrial SAN preparations of WT (black dots, n=6) and HCN4 FEA (orange dots, n=7). 
(E) Leading pacemaker position of WT before (black dots) and during VNS (red dots). Pacemaker position shifted 
in n=4 WT SAN preparations. (F) Leading pacemaker position of HCN4 FEA before (orange dots) and after VNS 
(red dots). Pacemaker position shifted in n=4 HCN4 FEA SAN preparations towards the IVC, IAS, and the AVJ.  
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In conclusion, analysis of mice lacking CDR of HCN4 channel on the network level of the SAN 
revealed higher beating rate variability, reduced firing rates of the SAN and prolonged SACT. 
However, the origin of impulse formation and the conduction pathways towards the atria were 
not impaired in HCN4 FEA mice. VNS of HCN4 FEA preparations caused an overshooting, 
inappropriate HR response. All these findings are comparable with the discoveries in vivo of 
the present thesis where intrinsic vagus nerve activity led to an overshooting HR reaction. 
Overall, these findings indicate that CDR of HCN4 channels holds a function as a dampener 
and antagonist of parasympathetic inputs to the HR.  
4.3.3 Role of CDR of HCN4 channels in single cells within the intact SAN 
network 
In a separate experiment, performed by Konstantin Hennis, long-term patch clamp recordings 
of isolated pacemaker cells derived from HCN4 FEA mice revealed that regular firing of the 
cells was temporarily interrupted by periods of electrical silence. This mode of intermittent firing 
was characterized by slow and progressive hyperpolarization of the membrane potential until 
firing was completely suppressed. These findings implied the existence of an additional activity 
mode for pacemaker cells during which the cells are electrically silent. This phenomenon was 
also observed in WT SAN cells but with a lower incidence. For the present thesis, the question 
was raised, whether cells during non-firing mode are apparent in the SAN cellular network 
where cells are connected via gap junctions. Therefore confocal calcium imaging of intact 
whole mount SAN preparations was performed. A preliminary experiment performed by René 
Rötzer confirmed, that measurements of calcium transients can be used as reliable readout 
for activity mode of SAN cells.  
Calcium imaging of WT preparations using Fluo-4 AM demonstrated rhythmic and global 
calcium transients in pacemaker cells embedded in the SAN network. By contrast, scanning 
of HCN4 FEA SAN explants uncovered small subsets of SAN cells exhibiting localized and 
spontaneous calcium transients during diastole (Fig. 34). In general, these local calcium 
releases were at a subthreshold level and therefore did not result in global calcium transients. 
Moreover, these calcium signals were self-limiting and in some cases triggered calcium signal 
propagation towards neighboring cells which indicates an interaction between adjacent cells. 
The entire SAN of WT (n=8) and HCN4 FEA (n=8) was scanned for cells exhibiting 
spontaneous calcium releases and number of cells observed was determined (Fig. 34C). 
HCN4 FEA SAN showed a significantly higher amount of cells in the non-firing state within the 
SAN network compared to WT (N cells/µm2[*10-3]basal; WT: 0.60 ± 0.16; HCN4 FEA: 
1.51 ± 0.35; p = 0.0330) (Table 6). In a next step it was tested if disruption of HCN4 CDR was 
in fact the cause for spontaneous calcium waves in HCN4 FEA SAN. Therefore, TAT-
TRIP8bnano 81 a small peptide that blocks CDR of HCN4 was applied to WT SAN 
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preparations (n=4). Interestingly, WT SAN thereupon showed a significant increase of the 
fraction of cells exhibiting localized calcium release (N cells/µm2[*10-3]Trip8bnano; WT: 4.24 ± 1.41; 
p= 0.0039, compared to WT basal), thus confirming the assumption that HCN4 CDR is 
mandatory to maintain a stable SAN cellular network activity and prevents switching of 
pacemaker cells to the non-firing mode.  
 
Fig. 34 Confocal calcium recordings to identify non-firing pacemaker cells within the SAN network.  
(A) Representative sequential series images of confocal calcium recordings using the calcium indicator Fluo-4-AM 
(fluorescence in arbitrary units [a.u.]) in intact SAN preparations of WT, HCN4 FEA and WT treated with TAT-
TRIP8bnano. Localized calcium signals are marked by red arrows. (B) Time course of the calcium transient of WT 
SAN. Numbers 1 – 4 mark the time of the images shown in (A). Spontaneous calcium transients occur during 
diastole (number 1 and 2). (C) Mean number of cells per µm2 of the entire SAN displaying subthreshold calcium 
transient. All values are given in mean ± SEM; *p<0.05; n(WT)=8, n(HCN4 FEA)=8; n(WT+TRIP8bnano)=4. 
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5 Discussion 
The present work focuses on the establishment of two methods to perform a 
cardiophysiological analysis of the genetic modified mouse model HCN4 FEA. It was aimed at 
specifically determining the role of cAMP-dependent regulation (CDR) of HCN4 channels 
within the sinoatrial node (SAN).  
5.1 Optical mapping to study cardiac electrophysiology  
In the present thesis the method of optical mapping was applied to murine whole hearts and 
biatrial SAN preparations with and without preserved vagus nerve. The method was 
established to identify the pathology of disrupted CDR of HCN4 channels specifically on the 
SAN network level. Optical mapping is a method to precisely visualize electrical processes 
within the intact cardiac tissue. Therefore, it provides a useful tool to investigate the cardiac 
phenotype of genetically modified mouse models. It is particularly useful to examine cardiac 
pacemaker function. A wide range of cardiac studies on animal models are limited to 
investigations on the in vivo or whole heart level by using ECG, echocardiography or 
electrophysiological studies. These investigations focus mainly on the whole heart automaticity 
and not primarily on the SAN. Further data of SAN function are usually given by isolated single 
cell electrophysiological investigations. However, to understand pacemaker function in its 
entirety, SAN cell-to-cell coupling and the functional anatomy of the pacemaker complex 
should not be overlooked when interpreting results. For the development of novel treatments 
for SAN dysfunction in human it is necessary to understand the SAN physiology on the network 
level.  
Optical mapping uses fast-voltage-sensitive dyes to map electrical signals in the intact heart. 
Dyes are embedded in the plasma membrane of the cells and linearly follow transmembrane 
voltage changes by a change in the emission spectrum. High-spatiotemporal resolution of the 
applied optical method allowed for exact representation of electrical processes in the heart and 
provided closer insights in the structure of the SAN region. Isochronal activation maps obtained 
by optical recordings revealed the exact pattern of activation and the location of the leading 
pacemaker site within the SAN. It led to an understanding of the hierarchic structure within the 
SAN built by the leading pacemaker region and by multiple subsidiary pacemakers as 
published by Glukhov et al 13. In addition, a block zone in direction to the IAS and LA as well 
as particular SACPs that conduct the signal towards the RA have been made visible by optical 
mapping of biatrial SAN preparations. A related method is the usage of microelectrode arrays, 
which are mounted on the cardiac surface. The signals obtained are not affected by contraction 
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artifacts or by scattering due to epicardial fat tissue. However, surface microelectrode arrays 
exhibit a lower spatial resolution and are not strong enough to detect the precise origin of 
excitation within the SAN 90. Furthermore, it does not provide the exact SAN structure including 
conduction pathways from the SAN towards the RA 91,92.  
Optical mapping provided a large field of view and offered the advantage to investigate the 
entire spectrum of heart excitation on the epicardial or endocardial side of the heart. Electrical 
stimulation of the SAN preparations did not interfere with the optical signals. ECG data of 
HCN4 FEA mice provided an idea of the cardiac phenotype but optical mapping elucidated the 
exact origin of arrhythmias (IAVD and JER) and the SAN network function.  
5.2 Combined telemetric ECG and BP recordings to estimate BRS 
In the present work BRS was estimated by the sequence method that analyses spontaneous 
BP and HR fluctuations. The method was customized to only detect reflectory HR changes 
driven by vagus nerve activities. Traditional techniques to estimate BRS are the bolus 
injections of vasoconstrictors (e.g. phenylephrine) or vasodilators (e.g. sodium nitroprusside). 
However, due to the immediate effect of these drugs on hemodynamics, BRS can only be 
measured in anesthetized mice or after a complex implantation of an infusion catheter 71. In 
addition, the bolus injection of vasoactive drugs has been considered to be an excessive and 
less physiological stimulus for reflex changes in HR to BP alterations 93. A considerable 
advantage of the sequence method is the fact that it is a noninvasive technique that provides 
data on spontaneous BRS in real life conditions 94. Another equally appropriate method to 
estimate BRS and the effect of dynamic vagus nerve activity on HR is assumed to be the 
spectral method. It assesses BRS in the frequency domain by calculation of the ratio between 
changes in HR and changes in blood pressure in a specific frequency band 93,95. 
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5.3 Cardiophysiological analysis of a mouse model with disrupted CDR of HCN4 
channels 
The heart function of HCN4 FEA mice was investigated on the whole-animal level, the isolated 
organ level and on the cellular level:  
(1) Studies on the in vivo level by ECG and BP measurements were implemented.  
(2) The pacemaker function was investigated in vitro on the SAN network level by optical 
experiments and electrical recordings of explanted heart preparations.  
(3) The single pacemaker cell function within the intact SAN network was tested in vitro by 
confocal calcium imaging and correlated with data obtained by single cell patch-clamp 
recordings. 
 
5.3.1 Chronotropic incompetence in vivo due to loss of CDR of HCN4 channels 
Long-term telemetric ECG recordings of HCN4 FEA mice revealed severe bradycardia, 
frequent sinus pauses, and SAN dysrhythmia as well as two specific forms of arrhythmias, JER 
and IAVD. 
A severe sinus bradycardia of HCN4 FEA mice became evident by long-term HR analysis and 
by study of HR histograms. Importantly, observed bradycardia was not due to a reduced 
activity behavior of HCN4 FEA mice. While maximum, minimum and average HR values were 
reduced in HCN4 FEA, dynamic range and degree of HR regulation were both similar to WT 
mice. This indicated that the principle HR regulation by the ANS was not affected in case of 
disrupted CDR of HCN4 but the whole range of HR regulation was shifted to lower HR values.  
In line with the observed chronotropic incompetence marked by bradycardia, escape 
phenomena arose in heart rhythm of HCN4 FEA mice. ECG data of HCN4 FEA mice revealed 
frequent phases of accelerated HR accompanied with JER and IAVD. Optical mapping of 
explanted and perfused whole hearts demonstrated that these forms of arrhythmia were 
characterized by the activity of two independent pacemaker sites. The leading pacemaker 
within the SAN drove the atria while a subsidiary pacemaker close to the AVN drove the 
ventricles or even retrogradely activated the atria. Under physiological conditions the SAN 
firing rates exceed the firing rates of the AVN by what the AVN activity is suppressed. AVN 
acts as secondary pacemaker in case of SAN failure. In the absence of CDR of HCN4 channels 
the intrinsic firing rates of the SAN were reduced and close to the intrinsic firing rates of the 
AVN whereby it took over heartbeat generation at times. During IAVD the AVN firing rates 
came near to that of the SAN and overtook ventricular activation. During JER the AVN firing 
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rates exceeded and outpaced the SAN firing rates to retrogradely activate the atria.  
These observations demonstrated that the SAN of HCN4 FEA mice was chronotropically 
incompetent whereas the subsidiary pacemaker showed unimpaired chronotropic 
competence. This is suggested to be due to reduced HCN4 expression levels in AVN 
compared to the SAN region 27,96. Accordingly, it explains a lower impact of disrupted CDR of 
HCN4 channels on the AVN. In addition, it is considered that during sympathetic activity AVN 
firing rates in HCN4 FEA mice accelerated, whereby SAN firing lagged behind AVN rhythm 
and escape phenomena occurred. Furthermore, high HR values in HR histograms of HCN4 
FEA mice displayed by a second peak in the high frequency range were attributable to JER. 
Notably, after excluding episodes during escape rhythm from HR analysis, the HR range of 
HCN4 FEA mice was still preserved.  
Further analysis of telemetric ECG recordings revealed increased HRV parameters and 
poincaré plots showing higher beat-to-beat dispersion in HCN4 FEA mice compared to WT, 
which is considered to be characteristic for SAN dysfunction 97. Blocking of the ANS by 
application of propranolol and atropine reduced HRV in HCN4 FEA mice and thus confirmed 
that increased HRV parameters were mainly attributable to ANS influences. These data 
indicated that after loss of HCN4 CDR, the SAN was more prone to perturbating influences like 
parasympathetic or sympathetic inputs. These findings were further confirmed by combined 
telemetric ECG and BP recordings and determination of BRS. The applied method, the 
sequence method, to estimate BRS revealed that dynamic increase and decrease in vagus 
nerve activities led to overshooting and inappropriate HR responses in mice lacking CDR of 
HCN4 channels.  
To conclude, these data demonstrate that the SAN is highly sensitive to ANS inputs in the 
absence of HCN4 CDR. Furthermore, it indicates that CDR of HCN4 dampens and counteracts 
parasympathetic effects on the HR. These findings are in line with the work of Fenske and 
colleagues 3,28 who described that one role of HCN channels is to stabilize and dampen 
transient changes in membrane potential and fluctuations in firing rates of the SAN.  
5.3.2 Instabilities of the SAN network in vitro due to loss of CDR of HCN4 
channels 
In vitro SAN preparations, where the system was dissociated from the ANS displayed a 
reduced firing rate and increased HR fluctuations. These findings point to the presence of SAN 
dysfunction and intrinsic instabilities of the SAN network due to disrupted CDR of HCN4 
channels. Optical mapping of biatrial SAN preparations revealed a decreased SACT in HCN4 
FEA compared to WT. However, this was not due to an altered functional pacemaker anatomy 
as, during basal conditions, activation maps of WT and HCN4 FEA demonstrated no 
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differences in the activation pattern or the origin of excitation. The leading pacemaker site in 
both phenotypes was mainly located in the head of the SAN and all preparations showed two 
distinct SACPs that conduct pacemaker signals towards the RA. During basal measurements 
the leading pacemaker site remained stable in its position within the territory of the SAN. 
Fluctuations in beating rates in HCN4 FEA preparations were not related to a competition of 
beat-to-beat multiple pacemakers in SAN as shown for example in calsequestrin 2 deficient 
mice suffering from SAN dysfunction 15.  
Telemetric data indicated that after loss of HCN4 CDR, SAN network was more prone to 
perturbating influences like inputs from the ANS. To further test this hypothesis on the SAN 
network level, carbachol, an ACh analogon, was applied to biatrial SAN preparations in order 
to mimic parasympathetic activation by decreasing cAMP levels. This led to a marked decrease 
in beating rates in WT and HCN4 FEA explants. So far, it has been shown that a change in 
HR is accompanied with an anatomical shift of the leading pacemaker within the SAN region 13. 
This was proven in the present thesis by optical mapping and the identification of the first 
excitation site: carbachol application led to a shift of the leading pacemaker position in direction 
of the IVC and AVJ, to a same extent in both phenotypes. To test the system under more 
physiological conditions a biatrial SAN preparation containing the right vagus nerve was 
established for the present thesis. It showed that vagus nerve stimulation induced a more 
physiological, pulsatile, and transient release of ACh that led to a temporary decrease in 
beating rates and to a pronounced shift of the leading pacemaker. Notably, HCN4 FEA 
preparations demonstrated an overshooting response with phases of large decrease in firing 
rate and a disorganized and large shifting of the leading pacemaker to peripheral portions of 
the SAN preparation. These findings demonstrate that the role of CDR is more pronounced in 
the head region of the SAN possibly due to a higher HCN4 expression compared to the tail 
region 69. 
This dataset also showed that application of parasympathomimetic drugs and direct vagus 
nerve stimulation are incomparable. A reason for this might be that stimulation of the vagus 
nerve leads to a more localized and short-term release of ACh by postganglionic nerve endings 
supplying the SAN. Thereupon, ACh reacts only with muscarinic receptors located in the 
synaptic cleft. By contrast, superfusion of the SAN preparation with carbachol provides free 
access to the entire surface of the SAN to be stimulated. A different set of receptors gets 
activated which possibly increase the potassium conductance of pacemaker cells. This 
incomparability of the two methods has been discussed by Campell and colleagues in 1989 98, 
however, ACh or carbachol application is often used as a correlate for vagus nerve 
stimulation 99. On the other hand, Lang and colleagues 100 used information gathered by 
ACh-induced shift of the leading pacemaker to elucidate gradient expression of ACh-sensitive 
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channels within the SAN. Their mathematical model provided instructive insights into the 
anatomically heterogeneous expression of ACh-sensitive channels within the SAN. 
5.3.3 Non-firing activity mode of pacemaker cells within the SAN network 
regulated by CDR of HCN4 channels 
In addition to the experiments presented in the present thesis, in long-term patch clamp studies 
performed by K. Hennis 4,101 it was discovered that single SAN cells of HCH4 FEA mice fired 
rhythmically but frequently entered an activity mode characterized by hyperpolarized 
membrane potentials. During these phases the cells stopped firing and only recovered as soon 
as membrane potentials slowly shifted to more positive values. Notably, WT cells rarely 
demonstrated periods of electrical silence but did so when intracellular cAMP levels were 
lowered by application of carbachol. So, these findings provided evidence for a so far 
undiscovered activity mode of pacemaker cells regulated by CDR of HCN4 channels. 
The finding that single pacemaker cells are able to access a non-firing activity mode, was 
confirmed in the present thesis by confocal calcium measurements of single cells in the intact 
SAN network, where cells are electrically connected via gap-junctions. Cells in the non-firing 
mode were also observed on the SAN network level and more frequently in HCN4 FEA SAN 
preparations compared to WT SAN. Blocking CDR of HCN4 channels by application of 
TAT-TRIP8bnano induced non-firing mode in WT SAN cells and thereby mimicked the effect 
observed in HCN4 FEA. The cell-penetrating peptide TAT-TRIP8bnano compete with cAMP for 
the same binding site in the C-helix of the CNBD of HCN channels and was able to totally 
abolish cAMP modulation of WT HCN4 channels 81. The effect of TAT-TRIP8bnano was even 
higher compared to the FEA mutation as it resembled a complete knockout of HCN4 CDR and 
hence shifted the activation threshold to dramatically hyperpolarized values in accordance with 
the work of Harzheim et al. 48. In physiological conditions basal cAMP levels in cytoplasm of 
SAN cells are required to constantly preactivate HCN4 channels 102. This condition was 
provided in HCN4 FEA mice by the exchange of Y527 to phenylalanine.  
Hyperpolarization-mode in pacemaker cells due to disrupted CDR of HCN4 can be explained 
as follows. HCN4 channels provide a depolarizing current, Ih, that maintains a well-balanced 
relationship between depolarizing and hyperpolarizing input currents. In WT, both 
hyperpolarization and cAMP increase HCN4 channel activity and thereby are able to 
counteract arising hyperpolarizing currents. By contrast, HCN4 FEA channel activity can only 
be accelerated by hyperpolarization, the channels’ fine-tuning by cAMP is lacking. Thus, HCN4 
FEA channels are not able to counterbalance hyperpolarizing offset currents as efficiently as 
WT HCN4 channels do. As a result, membrane potential progressively slides into direction of 
hyperpolarization until firing is completely suppressed. In summary, CDR of HCN4 channels is 
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required for maintaining a stable firing activity in pacemaker cells and for its restoration in non-
firing mode cells.  
The present thesis further elucidated the importance of electrically silent cells for electrical 
conduction and impulse formation within the intact SAN network. Altered SAN function in HCN4 
FEA mice can be explained by the presence of more non-firing cells within the SAN network. 
More hyperpolarized cells exert a pull on the positive charges of more depolarized, adjacent 
cells and thereby act as a current sink. A source-sink model of signal transmission describes 
depolarized cells as source and resting cells as sink, whereby impulse propagation depends 
on the source-sink relation. During AP propagation positive charges from the source cells flow 
into sink cells until the activation threshold of the sink cells is reached 22,103. Cells that are 
concurrently in the electrical silent mode are supposed to form a functional network that slows 
down pacemaking of firing cells or rather leads to a slowing down of sinoatrial conduction of 
APs. This phenomenon explains prolonged SACT in HCN4 FEA SAN preparations.  
Confocal calcium recordings of intact SAN preparations performed in the present thesis 
revealed that cells in the non-firing mode are characterized by localized spontaneous calcium 
signals during diastole. These signals did not lead to global calcium transients as observed. In 
the given context, this subthreshold calcium activity can be explained by the cation flow from 
more depolarized cells to hyperpolarized cells. In addition, localized calcium activity was never 
observed in single pacemaker cells and only occurred in the SAN network as evidenced by 
preliminary experiments of R. Rötzer 101. To conclude, in WT we found a source-sink balance. 
But in HCN4 FEA disruption of CDR of HCN4 channels led to a source-sink mismatch with 
more cells in the non-firing mode that inhibited firing cells. The described mechanism explains 
slowed impulse formation, reduced SACT, and SAN dysfunction observed in HCN4 FEA SAN 
preparations.  
These findings of a so far unknown activity mode of pacemaker cells regulated by CDR of 
HCN4 channels explain the shift of the leading pacemaker site during vagus nerve stimulation 
in WT as well as the pronounced shift in HCN4 FEA SAN preparations. In the head region of 
the SAN HCN4 expression is higher compared to inferior parts of the SAN and parts closer to 
the AV junction 69. Therefore, the impact of CDR of HCN4 channels and of inputs from the ANS 
are more pronounced. During parasympathetic activities pacemaker cells in the superior part 
of the SAN are more prone to switch to the non-firing mode which leads to a slowing of impulse 
generation in the SAN head region. At the same time fewer cells in the peripheral region of the 
SAN are non-firing and therefore the network in this region fires faster than the SAN head 
region. As a consequence, lower portions of the SAN overtake impulse formation (Fig. 35). 
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Fig. 35 Schematic overview of the mechanism underlying the leading pacemaker shift during parasympathetic 
activity. Schematic illustration of the heart, left. Vagus nerve (VN), autonomic ganglia complex (GC) and epicardial 
nerve fibres that innervate the SAN are plotted in red. Territory of the SAN is depicted in blue. Color gradient 
represents HCN4 expression levels within the SAN. Cells in the head region of the SAN show a higher HCN4 
expression compared to the tail region of the SAN. Right panel shows the SAN network with pacemaker cells in the 
firing mode in green and cells in the non-firing mode in grey and the corresponding APs of the particular SAN 
regions. During basal conditions the leading pacemaker is located in the head region of the SAN. Vagus nerve 
stimulation (VNS) leads to a switch of pacemaker cells to the non-firing mode but to a higher extent in the head 
region of the SAN. This leads to a more pronounced reduction in pacemaking in the head region compared to the 
tail region. As a result, the leading pacemaker (LP) shifts in direction of parts located more inferior within the SAN. 
In HCN4 FEA hearts this effect is more pronounced compared to WT. An increased number 
of cells switch to the non-firing mode and constitute an enlarged inhibitory network that slows 
down pacemaking and facilitates shifting of the leading pacemaker even to portions outside of 
the territory of the SAN.  
In summary, CDR of HCN4 channels is not required for principal HR regulation by the ANS as 
proposed by Bucchi et al 104 but provides stabilizing and dampening properties on the SAN 
network function and pacemaker activity. It is suggested that CDR of HCN4 channels plays a 
key role in regulating a newly identified component of the chronotropic effect which is 
characterized by the non-firing mode of pacemaker cells. 
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6 Outlook 
The present study demonstrates that dependencies of autonomic regulation, CDR of HCN 
channels, and SAN network function are obvious and confirms experiments done by 
DiFrancesco 21,105. However, the underlying mechanism of autonomic HR regulation through 
CDR of HCN4 channels is more complex than originally proposed. The role of CDR of HCN4 
in regulating the non-firing mode of pacemaker cells is a novel finding and merits further 
research. This new perspective on pacemaker cell regulation could clarify the role of HCN 
expression in other organ pacemaker cells like interstitial cells of cajal in the gastrointestinal 
tract 25 or the urinary bladder 26, where the channels are not required for the generation of 
pacemaker potentials but are suggested to play a regulatory role for pacemaker activity. 
In the context of the present work it would be of further interest to investigate the effect of 
sympathetic stimulation on the SAN function in HCN4 FEA mice. This question could be 
experimentally addressed by the application of a sympathomimetic drug like isoproterenol, or 
through direct stimulation of cardiac sympathetic nerves. Furthermore, extended research on 
the non-firing mode of pacemaker cells could be introduced by a combination of calcium and 
voltage confocal imaging of pacemaker cells within the SAN network. Confocal imaging of SAN 
preparations with preserved vagus nerve might be of great interest to demonstrate pacemaker 
cells switching into the non-firing mode during vagus nerve stimulation. In vivo, a surgical 
removal of the cardiac parasympathetic nerves, a vagotomy, in HCN4 FEA mice could provide 
further data to elucidate the impact of parasympathetic activity on SAN dysfunction in mice 
with disrupted CDR of HCN4 channels.  
The cardiac phenotype of HCN4 FEA mice including sinus dysrhythmia, pathological 
bradycardia and chronotropic incompetence is comparable with symptoms observed in human 
patients with sick sinus syndrome 106. The mechanisms discovered are considered to be 
translatable to human SAN function. Although the absolute HR values differ between the two 
species, the relative dynamic range of HR regulation is similar. For the development of novel 
treatments for SAN dysfunction in human disease, it is crucial to understand the underlying 
physiology of the SAN and its regulation by the ANS. Thus, the findings may have direct impact 
on future treatment of human arrhythmias. 
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7 Summary 
HCN4 channels within the SAN of the heart play a pivotal role for the pacemaker function of 
SAN cells. Together with other members of the HCN channel family, the current passing HCN4 
channels is considered to be fundamental regarding the automaticity of the SAN by contributing 
to spontaneous depolarization of the membrane potential initiating an action potential. It is 
commonly known that HCN4 channels are activated upon hyperpolarization and that the gating 
of the channel is facilitated by binding of cAMP. However, the specific role of CDR of HCN4 
channels had not yet been clarified.  
The findings of the present thesis provide evidence that CDR of HCN4 is not required for 
principal HR regulation through the ANS, but plays an important role in stabilizing HR and the 
sinoatrial network activity. Loss of CDR of HCN4 leads to chronotropic incompetence and to 
an overshooting, inappropriate response of the HR to parasympathetic activity. In addition, 
lack of CDR of HCN4 decelerates HR in general which triggers the occurrence of arrhythmia.  
The present study together with preliminary work of lab colleagues (S. Fenske, K. Hennis and 
R. Rötzer 101) elucidated a previously undiscovered activity mode of pacemaker cells regulated 
by CDR of HCN4 channels. It was found that pacemaker cells do not continuously fire, but are 
able to switch temporarily into a non-firing electrical silent mode. Non-firing cells build an 
inhibitory network within the SAN that slows down pacemaking of firing cells. During inputs 
from the vagus nerve, CDR of HCN4 counteracts the increase of the inhibitory network by 
preventing cells from switching to the non-firing mode. This additional activity mode of 
pacemaker cells increases the dynamic range of HR regulation and builds a so far unknown 
component of the chronotropic response. The non-firing mode of pacemaker cells may be 
important to preserve energy during continuous heartbeat generation, and additionally ensures 
regular pacemaker activity.  
The present work investigates the consequence of disrupted CDR of HCN4 on several cardiac 
levels: in vivo, in isolated whole hearts, in SAN preparations, and in single cells embedded in 
the SAN network. Therefore, two methods were established beforehand, tailored for the needs 
of this study, and were applied to a mouse model with disrupted CDR of HCN4 channels.  
First, visualization of electrical processes in the heart by optical mapping elucidated the 
functional anatomy of the SAN. The procedure uncovered the influence of the HCN4 
expression gradient within the SAN to the effect of parasympathetic inputs. In addition, optical 
mapping provided information not given by ECG recordings, like the exact origin of 
arrhythmias. Second, combined ECG and BP measurements and the implemented sequence 
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method to obtain the gain of baroreflex led to a better understanding of the role of CDR of 
HCN4 to the interaction of the brain with the SAN pacemaking.  
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ACh Acetylcholine 
ANEP Aminonaphthylethenylpyridinium 
ANS Autonomic nervous system 
AO Aorta 
AP Action potential 
APD Action potential duration 
ATP Adenosine triphosphate 
AV delay Atrio-ventricular delay 
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AVJ Atrio-ventricular junction 
AVN Atrioventricular node 
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CDR cAMP-dependent regulation 
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CNG Cyclic nucleotide-gated 
CT Crista terminalis 
Cx Connexin 
DBP Diastolic blood pressure 
DMSO Dimethyl sulfoxide 
DNA Deoxyribonucleic acid 
ECG Electrocardiogram 
FFT Fast Fourier transform 
FIR filter Finite impulse response filter 
G protein Guanine nucleotide-binding protein 
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11 Appendix 
11.1 Tables of data 
Table 1: Heart rate analysis of 72 h telemetric ECG recordings  
Parameter WT n HCN4 FEA n p-value 
HR mean 72h 
[bpm] 
522.91 ± 8.33 9 435.88 ± 13.64 11 0.00007 
HR max 72h 
[bpm] 
726.65 ± 9.25 9 662.82 ± 16.15 11 0.00467 
HR min 72h 
[bpm] 
355.25 ± 8.52 9 299.70 ± 11.27 11 0.00136 
Dynamic range 
72h [bpm] 
371.40 ± 12.72 9 363.12 ± 18.46 11 0.72857 
Degree of HR 
reg 72h [bpm] 
2.05 ± 0.05 9 2.24 ± 0.09 11 0.12640 
HR mean LA 
[bpm] 
501.52 ± 11.13 9 417.00 ± 13.68 11 0.00020 
HR max LA 
[bpm] 
707.91 ± 12.22 9 642.22 ± 15.68 11 0.00508 
HR min LA [bpm] 362.87 ± 9.64 9 299.70 ± 11.27 11 0.00061 
Dynamic range 
LA [bpm] 
345.04 ± 9.15 9 342.53 ± 17.34 11 0.90590 
Degree of HR 
reg LA [bpm] 
1.96 ± 0.04 9 2.17 ± 0.09 11 0.05674 
HR mean HA 
[bpm] 
544.10 ± 6.89 9 454.75 ± 13.81 11 0.00004 
HR max HA 
[bpm] 
720.64 ± 7.49 9 661.60 ± 16.41 11 0.00563 
HR min HA [bpm] 375.03 ± 11.61 9 313.79 ± 12.95 11 0.00289 
Dynamic range 
HA [bpm] 
345.61 ± 13.47 9 347.82 ± 18.95 11 0.92852 
Degree of HR 
reg HA [bpm] 
1.94 ± 0.06 9 2.14 ± 0.10 11 0.11110 
Mean ± SEM; n= number of animals 
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Table 2: Time domain and frequency domain analysis of telemetric ECG data 
Parameter WT n HCN4 FEA n p-value 
RR [ms] 
132.24 ± 2.67 9 151.59 ± 5.05 11 0.0053 
SDNN [ms] 
11.60 ± 0.69 9 24.37 ± 2.28 11 0.0001 
RMSSD [ms] 
9.38 ± 1.09 9 19.64 ± 2.53 11 0.0029 
VLF power 
[√ms/Hz] 
10.63 ± 2.82 9 64.17 ± 12.54 11 0.0014 
LF power 
[√ms/Hz] 
9.22 ± 3.05 9 77.46 ± 32.45 11 0.0754 
HF power 
[√ms/Hz] 
11.66 ± 3.44 9 42.29 ± 12.61 11 0.0468 
Mean ± SEM; n= number of animals; 
 
Table 3: Analysis of combined telemetric BP and ECG data 
Parameter WT n HCN4 FEA n p-value 
RR [ms] 
124.77 ± 2.96 9 155.70 ± 5.62 11 0.0002 
DBP [mmHg] 
86.33 ± 2.01 9 79.17 ± 1.92 11 0.0196 
SBP [mmHg] 
112.62 ± 1.57 9 111.05 ± 2.55 11 0.6241 
Sequences/1000 
beats 
23.72 ± 4.76 9 19.02 ± 3.52 11 0.4282 
Slopeup 
[ms/mmHg] 
4.21 ± 0.25 9 7.63 ± 1.23 11 0.0238 
Slopedown 
[ms/mmHg] 
4.09 ± 0.39 9 8.93 ± 1.49 11 0.0103 
Mean ± SEM; n= number of animals 
 
Table 4: Electrical recordings of biatrial SAN preparations  
Parameter WT n HCN4 FEA n p-value 
Beating rate 
[bpm] 
302.91 ± 7.42 26 247.28 ± 11.85 31 0.0004 
SDNN [ms] 
4.18 ± 0.76 26 14.98 ± 3.37 31 0.0057 
RMSSD [ms] 
4.44 ± 1.14 26 20.49 ± 5.01 11 0.0057 
Mean ± SEM; n= number of animals 
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Table 5: Optical mapping and electrical recordings of biatrial SAN preparations  
Parameter WT n HCN4 FEA n p-value 
SACT [ms] 
4.86 ± 0.37 7 7.44 ± 0.57 8 0.0029 
Beating ratebefore 
Carbachol [bpm] 
288.20 ± 6.44 13 235.74 ± 14.19 16 0.0043 
Beating 
rateCarbachol [bpm] 
151.87 ± 5.63 13 109.55 ± 5.24 16 0.000008 
LP shiftCarbachol 
0.503 ± 0.075 7 0.624 ± 0.090 8 0.3261 
Beating ratebefore 
VNS [bpm] 
330.83 ± 18.76 6 322.5 ± 17.52 7 0.7620 
Mean RRVNS 20Hz 
[s] 
0.396 ± 0.053 6 0.491 ± 0.194 7 0.6676 
LP shiftVNS 20Hz 
0.478 ± 0.177 4 1.044 ± 0.119 4 0.0381 
Mean ± SEM; n= number of animals 
 
Table 6: Confocal calcium recordings of SAN cell within the intact SAN network 
Parameter WT n HCN4 FEA n p-value 
N cells/µm2    
[*10-3]basal 
0.60 ± 0.16 8 1.51 ± 0.35 8 0.0330 
N cells/µm2    
[*10-3]TRIP8bnano 
4.24 ± 1.41 4 --- 
 
--- 
--- 
--- 
Mean ± SEM; n= number of animals 
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